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ABSTRACT 
 
Apoptosis is essential for development and the maintenance of cellular homeostasis and 
is frequently dysregulated in disease states.  Proteins of the BCL-2 family are key modulators of 
this process and are thus ideal therapeutic targets.  In response to diverse apoptotic stimuli, the 
pro-apoptotic member of BCL-2 family, BAX, redistributes from the cytosol to the mitochondria 
or endoplasmic reticulum and primes cells for death.  The structural changes that enable this 
lethal protein to transition from a cytosolic form to a membrane-bound form remain poorly 
understood.  Elucidating this process is a necessary step in the development of BAX as a novel 
therapeutic target for the treatment of cancer, as well as autoimmune and neurodegenerative 
disorders.  
A three-part study, utilizing computational modeling and biological assays, was used to 
examine how BAX, and similar proteins, transition to membranes.  The first part tested the 
hypothesis that the C-terminal α9 helix regulates the distribution and activity of BAX by 
functioning as a “molecular switch” to trigger conformational changes that enable the protein to 
redistribute from the cytosol to mitochondrial membrane. Computational analysis, tested in 
biological assays, revealed a new finding: that the α9 helix can dock into a hydrophobic groove 
of BAX in two opposite directions – in a self-associated, forward orientation and a previously, 
unknown reverse orientation that enables dimerization and apoptosis.  Peptides, made to mimic 
the α9-helix, were able to induce the mitochondrial translocation of BAX, but not when key 
residues in the hydrophobic groove were mutated.  Such findings indicate that the α9 helix of 
BAX can function as a “molecular switch” to mediate occupancy of the hydrophobic groove and 
regulate the membrane-binding activity of BAX.  This new discovery contributes to the 
 iii
understanding of how BAX functions during apoptosis and can lead to the design of new 
therapeutic approaches based on manipulating the occupancy of the hydrophobic groove. 
The second and third parts of the study used computational modeling to examine how the 
helical stability of proteins relates to their ability to functionally transition.  Analysis of BAX, as 
a prototypical transitioning protein, revealed that it has a broad variation in the distribution of its 
helical interaction energy.  This observation led to the hypothesis tested, that proteins which 
undergo 3D structural transitions during execution of their function have broad variations in the 
distribution of their helical interaction energies.  The result of this study, after examination of a 
large group of all-alpha proteins, was the development of a novel, predictive computational 
method, based on measuring helical interactions energies, which can be used to identify new 
proteins that undergo structural transitioning in the execution of their function.  When this 
method was used to examine transitioning in other members the BCL-2 family, a strong 
agreement with the published experimental findings resulted.  Further, it was revealed that the 
binding of a ligand, such as a small peptide, to a protein can have significant stabilizing or 
destabilizing influences that impact upon the activation and function of the protein. This 
computational analysis thus contributes to a better understanding of the function and regulation 
of the BCL-2 family members and also offers the means by which peptide mimics that modulate 
protein activity can be designed for testing in therapeutic endeavors.  
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1 GENERAL INTRODUCTION 
1.1 Introduction 
 
Apoptosis is a form of cell death by which a programmed series of events leads to the 
cell’s demise without initiating the release of intracellular contents that could provoke an 
inflammatory response (Nelson, White 2004). A multi-cellular organism typically eliminates 
unnecessary or damaged cells through the process of apoptosis (Borner 2003;Cory et al. 
2003;Nelson, White 2004).  Malfunctions in the regulation of apoptosis characterize a range of 
human diseases, including cancer, neurodegenerative, cardiovascular and autoimmune disorders 
(Cory et al. 2003;Gross et al. 1999). Diseases caused by excessive cell death, such as myocardial 
and cerebral ischemia, are two of three leading causes of death in the developed world (Letai 
2005).  Cancer, the third leading causing of death in the developed world, is also caused in part 
by the defects in the cell death process. It is therefore of great importance that the process of 
apoptosis be studied in order to develop novel regimens for therapeutic intervention. 
The apoptotic pathway can be initiated by different mechanisms.  A physiological 
relevant pathway involves the release of apoptotic factors from mitochondria.  Modulators of 
mitochondria function and integrity are those proteins found in the BCL-2 (B Cell Lymphoma) 
family. The founder of the BCL-2 family, BCL-2, is a proto-oncogene whose activity is 
deregulated in a majority of patients with follicular lymphoma (Borner 2003;Gross et al. 
1999;Lipford et al. 1987).  Other BCL-2 family members include the anti-apoptotic proteins, 
BCL-XL, and the pro-apoptotic protein, BAX.  Murine models of myocardial and cerebral 
ischemia demonstrated that BAX loss-of function mutations or overexpression of BCL-2 could 
attenuate apoptosis and reduced infracts size (Letai 2005).  In contrast, transgenic mice 
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overexpressing BCL-2 developed leukemia (Borner 2003;Gross et al. 1999).  These examples 
illustrate the importance of the BCL-2 family member in the regulation of apoptosis in disease 
models, and suggest that BCL-2 family members are valid therapeutic targets.  
 
1.2 BCL-2 Family of Proteins 
 
Apoptosis is triggered by a range of physiological and pathological death signals. The 
best characterized pathways that lead to apoptotic cell death involve the activation of cysteine 
proteases of the caspase family that cleave substrates after aspartate residues (Earnshaw et al. 
1999). These enzymes are divided into two groups: (1) the initiator caspases (caspases 2, 8-10, 
12), and the effector caspases (caspases 3, 6, 7) (Earnshaw et al. 1999). An initiator caspase acts 
at an early point in the apoptotic signaling pathway. After autoproteolysis of the initiator 
caspases active dimers are forms which activate effector caspases through proteolitic cleavage 
and thus enhances the apoptotic signal (Earnshaw et al. 1999). Effector caspases than cleave the 
substrates which lead to the break-down of the cell into apoptotic bodies and subsequent 
phagocytosis (Utz, Anderson 2000). The initiator caspases are in mammals activated by at least 
two pathways: (1) the death-receptor pathway, and (2) the mitochondrial (BCL-2 family) 
pathway. The death-receptor pathway is initiated by extracellular death-inducing ligands of the 
TNF superfamily (Krammer 2000;Locksley et al. 2001). The mitochondrial pathway involving 
BCL-2 family proteins is mostly triggered by growth factors and cytokines withdrawal, 
irradiation, viruses, bacteria and chemotherapeutic drug (Borner 2003;Gross et al. 1999). Various 
BCL-2 family members serve as sensors of the death stimuli, other target mitochondrial outer 
membrane to release apoptogenic factors (e.g. cytochrome c, Smac/DIABLO, Htr2A/Omi) 
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involved in the formation of apoptosome in mammalian cells (Borner 2003;Bouillet, Strasser 
2002;Gross et al. 1999).   
Members of the BCL-2 family are crucial regulators of the mitochondrial apoptotic 
pathway. The founding member of this family, BCL-2, was initially cloned from the breakpoint 
of the t(14;18) chromosomal translocation in human B-cell lymphoma (Gross et al. 1999;Lipford 
et al. 1987).   Today this family is comprised of over 30 proteins, sharing one or more BCL-2 
homology (BH) domains.  Based on their function in apoptosis, the family is divided into two 
groups: (1) anti-apoptotic proteins like BCL-2 and BCL-XL which possess three to four BH 
domains, (2) pro-apoptotic proteins like BAX and BAK, which possess three to four BH domains 
and mediators like BIM that possess only one BH domain (BH3-only proteins) (Borner 
2003;Bouillet, Strasser 2002;Cory et al. 2003;Gross et al. 1999) (Table 1).  
In the absence of apoptotic stimuli, a significant fraction of pro- and anti- apoptotic BCL-
2 members sequester to separate subcellular compartments. Anti-apoptotic members like BCL-2 
and BCL-XL are largely found membrane-bound in mitochondrial outer membrane (MOM), 
endoplasmic reticulum (ER) or nuclear membrane (Borner 2003;Bouillet, Strasser 2002;Gross et 
al. 1999). Pro-apoptotic members like BAX localize to cytosol or like BIM to cytoskeleton 
(Borner 2003;Bouillet, Strasser 2002;Gross et al. 1999).  Upon induction of a death signal, 
significant subcellular rearrangement of various family members takes place indicative of their 
ability to transition.  Pro-apoptotic proteins, like BAX, translocate to membranes, especially 
MOM, where they are thought to cause destabilization of the MOM and induce release of the 
apoptogenic factors from the mitochondria (Table 1). 
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Table 1: Summary of the most prominent mammalian BCL-2 family members. 
BCL-2 family 
member 
Function BH 
homologies 
Localization in healthy 
cells 
Localization in apoptotic 
cells 
BCL-2 Anti-apoptotic BH1-BH4 MOM-, ER-, nuclear 
envelope inserted 
MOM-, ER-, nuclear 
envelope inserted 
BCL-XL Anti-apoptotic BH1-BH4 Cytosolic,  loosely MOM- 
attached 
MOM-inserted 
BCL-W Anti-apoptotic BH1-BH4 MOM – loosely attached MOM-inserted 
MCL-1 Anti-apoptotic BH1-BH4 MOM-, ER-, nuclear 
envelope inserted  
MOM-, ER-, nuclear 
envelope inserted 
     
BAX Pro-apoptotic BH1-BH3 Cytosolic, ER-, MOM- 
loosely attached 
MOM-inserted, ER-
inserted(?) 
BAK Pro-apoptotic BH1-BH3 MOM-, ER- inserted MOM-inserted, ER-
inserted 
     
BID BH3-only BH3 Cytosolic MOM 
BAD BH3-only BH3 Cytosolic MOM 
BIM BH3-only BH3 DLC1-associated MOM-inserted(?) 
 
 
Analysis of sequence homology among BCL-2 family proteins demonstrated that the 
family members posses low sequence homology, mostly limited to the BH regions. Mutagenesis 
studies of the BH1, BH2 and BH3 domains imply that these domains strongly influence homo- 
and hetero-dimerization of these proteins (Borner 2003;Gross et al. 1999).  Prevailing dogma 
states that the BH3 domain is responsible for mediating interactions between anti-apoptotic and 
pro-apoptotic proteins and between BAX-like pro-apoptotic and BH3-only proteins (Borner 
2003;Gross et al. 1999;Simonen et al. 1997). The sequence comparison among the BH3 domains 
of most prominent BCL-2 family proteins is presented in Table 2. 
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Table 2: The sequences of BH3 domains of most prominent BCL-2 family proteins. 
The strictly conserved residues of BH3 domains are in italic. 
 
BCL-2 family 
member 
Function BH3 domain sequence 
BCL-2 Anti-apoptotic VHLTLRQAGDDFSRR 
BCL-XL Anti-apoptotic VKQALREAGDEFELR 
   
BAX Pro-apoptotic LSECLRRIGDELDSN 
BAK Pro-apoptotic VGRQLALIGDDINRR 
   
BID BH3-only IARHLAQIGDEMDHN 
BAD BH3-only YGRELRRMSDEFEGS 
BIM BH3-only IAQELRRIGDEFNET 
 
 
Some studies indicate that the BH3 domain has the ability to promote apoptosis (Bouillet, 
Strasser 2002;Kuwana et al. 2005;Putcha et al. 2001;Simonen et al. 1997). This opinion was 
strengthened by subsequent studies which used peptides derived from the BH3 domain of pro-
apoptotic BCL-2 family members that bound to anti-apoptotic BCL-XL (Liu et al. 2003;Petros et 
al. 2004;Petros et al. 2000;Sattler et al. 1997).  Expression of small peptide derive from the BH3 
sequence of BAK was sufficient to induce apoptosis (Cosulich et al. 1997), small synthetic 
peptides derived from BH3 domains of the BH3-only proteins can suppress the  anti-apoptotic 
BCL-2 family members (Dharap et al. 2003;Minko et al. 2003;Shangary, Johnson 2002).  
In addition to the BH domains, many of the BCL-2 family members process a C-terminal 
hydrophobic domain, which is predicted to be responsible for membrane localization.  
Intriguingly enough, subcellular localization differs between the anti-apoptotic and pro-apoptotic 
proteins, and changes in the subcellular localization of these proteins upon apoptotic stimulus are 
characteristic of the early stages of apoptosis (Table 1).  BCL-2 is predominantly anchored in the 
outer mitochondrial membrane and this membrane localization plays a key role in the ability of 
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BCL-2 to modulate mitochondrial membrane integrity (Borner 2003;Gross et al. 1999).  The 
release of apoptogenic factors is inhibited by BCL-2 and BCL-XL.  Pro-apoptotic BAX resides 
in the cytosol of healthy cells and translocates to mitochondria upon apoptotic stimulus (Annis et 
al. 2005;Borner 2003;Gross et al. 1999). The release of the apoptogenic factors is enhanced by 
membrane-bound BAX.   
BH3-only proteins play a significant role in mediating a life or death decision.  There is 
increasing evidence in the literature that these proteins are apoptotic-stimulus specific and cell-
type specific.  BIM, for example, is required for induction of apoptosis in lymphocytes upon 
cytokine withdrawal (Bouillet, Strasser 2002;Dijkers et al. 2000), stimulation of autoreactive 
antigen receptors, or treatment with taxol (Bouillet, Strasser 2002;Puthalakath et al. 1999).  
Current dogma states that BH3-only proteins directly activate BAX-like proteins to trigger the 
mitochondrial membrane disruption and consequently apoptosis (Bouillet, Strasser 2002).  
However, for many of these proteins including BIM, no direct binding to BAX was observed. An 
alternative model suggests that BIM and related proteins initiate apoptosis by binding of the anti-
apoptotic proteins like BCL-2 and changing their conformation to enable the dimerization of 
BAX and the disruption of the mitochondrial membrane (Borner 2003).  
 
1.3 Structure and function of BAX 
 
The structure of BAX was determined in 2000 (Suzuki et al. 2000).  BAX consists of 
nine α helices with eight amphipathic α helices clustered around one central hydrophobic α helix 
(α5) (Figure 1, 2).  The overall fold of BAX closely resembles the fold of C-terminally truncated 
BCL-2 and BCL-XL.  Helices 2, 3, and 4 form a hydrophobic groove. A portion of the C-
 6
terminal region of BAX forms the helix α9 that binds within a hydrophobic groove, covering the 
hydrophobic residues of the groove and burying its own hydrophobic residues. 
 
 
 
 
 
 
 
Figure 1: The amino acid sequence of BAX with indicated secondary structure, BH 
domains and transmembrane domain. 
Complete amino acid sequence of BAX is shown in this figure. Alpha helices are in red, BH domains in 
yellow and transmembrane domain in green. 
 
This may be important for increasing the solubility of the protein and contributes to the 
fact that BAX exists predominantly in the cytosol before apoptosis induction.  Helix α9 is 
positioned in the hydrophobic pocket in a manner similar to the way the BH3 peptide of another 
BCL-2 family member, BAK, is positioned in the hydrophobic groove of BCL-XL(Sattler et al. 
1997).  In essence, the directional sense of the peptide is opposite to that of the self-associated C-
terminal helix of BAX.   
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Figure 2: Ribbon representation of BAX structure. 
The helices are numbered from 1-9, BH1 colored orange, BH2 blue, BH3 yellow, and α9 red. 
 
 
In previous studies, Khaled et al. reported that a rapid increase in intracellular pH, 
associated with cytokine withdrawal in lymphocytes, triggered that translocation of BAX to 
mitochondria(Khaled et al. 1999).  This concept led to the hypothesis that BAX undergoes 
conformational changes at pH 7.8 or higher.  However, NMR studies obtained by Suzuki at al. 
did not report any conformational changes at high pH (Suzuki et al. 2000).  Instead, they 
reported that BAX underwent conformational changes upon detergent treatment, which induced 
complex formation. This conformational changes exposed hidden epitopes that upon exposure 
were detectable by antibodies (Annis et al. 2005;Cartron et al. 2004;del Mar et al. 2001;Khaled 
et al. 1999).  Conformational changes in BAX resulted in complex formation upon detergent 
treatment or in presence of lipids (Antonsson et al. 2000;Antonsson et al. 2001;Hsu, Youle 
1998;Hsu, Youle 1997).   
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1.4  Molecular Modeling 
 
“Molecular modeling is the science and art of studying molecular structure and function 
though model building and computation” (Schlick 2006). Molecular modeling begins with the 
refinement of the experimental data obtained by X-ray crystallography and NMR, and continues 
with the ab initio and semi-empirical quantum mechanics and empirical mechanics, molecular 
dynamics, structure/activity relationships and databases (Hinchliffe 2006;Machida 2007;Schlick 
2006). Molecular modeling plays an important role in predicting structural and functional 
properties of increasing number of identified and characterized proteins. In my work I used 
empirical (molecular) mechanics approach. 
Molecular mechanics is known also under terms force-field or potential energy method 
(Allinger 1976). An underlying principle in molecular mechanics is that cumulative physical 
forces can be used to describe molecular geometries and energies. The spatial conformation 
eventually obtained is then a normal adjustment of geometry to minimize the total internal 
energy. Molecules are considered as a collection of masses centered at the nuclei (atoms) 
connected by springs (bonds) (Hinchliffe 2006;Machida 2007;Schlick 2006). Molecular 
mechanics involves assembly of a potential energy, a function of atomic positions. Entropic 
contributions are either neglected or approximated (Machida 2007;Schlick 2006). Several 
versions force fields are commonly used. Molecular mechanics 2/3/4 is often used for small 
molecular systems (Allinger 1976;Lii, Allinger 1998b) , CHARMM (Brooks et al. 1983) 
package is preferred by protein modelers, AMBER (Case et al. 2005) is often used by nucleic 
acid modelers.  
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1.5 Thesis Objectives 
 
Despite its critical importance in the apoptotic process, the mechanisms by which BAX is 
activated are still poorly defined.  Research to date has revealed that BAX resides in the cytosol 
of healthy cells and upon apoptotic insults translocates to the membranes of organelles, 
principally the mitochondria and the endoplasmic reticulum (Borner 2003;Bouillet, Strasser 
2002;Gross et al. 1999). Some progress has been made identifying possible proteins that could 
interact with BAX and mediate its membrane-binding activity. What is not known, however, is 
the actual means by which the apoptotic activity of BAX is triggered – what initiates the change 
from a cytosolic-form to a membrane-bound form.  Lack of this information represents an 
important medical problem because, without an understanding of the conformational and 
physiological triggers that regulate the activation of BAX, the therapeutic potential of 
manipulating this protein in disease states cannot be fully developed. Current studies in the use 
of therapeutic apoptosis, which focus on the inhibition of cell death through manipulating BCL-2 
family members, are in the early stages (Letai 2005). 
The first objective of the work presented herein was to characterize the “molecular 
switch” which mediates the activation of BAX and identify possible physiological triggers that 
could “flip the switch”.  Based on published data and my preliminary observations, I developed 
the hypothesis that the subcellular distribution of BAX was governed by its C-terminal domain, 
the α9 helix.  Published findings suggested that this domain functioned solely as a membrane 
anchor.  Based on my initial findings, I proposed to examine a different function: the α9 helix 
operates as a “molecular switch” in response to apoptotic stimuli, inducing conformational 
changes that enable subsequent membrane integration.  To validate this hypothesis, I employed 
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diverse methods of cell biology and computational modeling to demonstrate that basic residues 
in the α9 helix interact with residues in the α2 helix and hinge, which form part of a prominent 
hydrophobic groove, to mediate the subcellular localization of BAX.  Using peptide mimics of 
the C-terminal α9 helix, I showed that occupancy of the hydrophobic groove by the α9 helix 
mediates the translocation of BAX from cytosol to mitochondria.  To explore possible 
physiological triggers that could regulate the membrane-binding activity of the α9 helix, I 
observed that a transient raise in intracellular pH facilitated the movement of BAX to 
mitochondrial membrane, suggesting that the lipid bilayer of mitochondria could be a pH-
responsive component.  In total, these findings have significant implications for the development 
of novel therapeutic molecules for the modulation of apoptosis in drug development. 
Second objective of the work presented herein was to develop a computational method to 
identify proteins, like BAX, capable of undergoing structural transitioning. To date, no such 
methodology is available for this purpose.  Based on the computational analysis of helical 
packing energies in BAX, I developed the hypothesis that proteins which undergo significant 
conformational changes will have a broader distribution in their helical packing energies 
compared to less dynamic or static proteins. To test this hypothesis, multiple groups of proteins 
were analyzed by molecular mechanics 3 (MM3) and methods of computational analysis were 
developed to enable the prediction of which proteins which undergo conformational changes.  
These predications can be used to identify transitional proteins as well as transitional regions 
within proteins, indicating where changes are most likely to occur.  I used this computational 
tool to examine multiple members of the BCL-2 family and was able to correlate their propensity 
to transition, as indicated by variations in helical packing energy, to their function.  This work 
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contributes to the field of proteomics by providing a novel parameter by which transitional 
proteins can be identified for subsequent biological testing. 
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2  STRUCTURAL TRANSITIONS THAT MEDIATE THE MEMBRANE-
ASSOCIATION ACTIVITY OF BAX ARE DEPENDENT ON ITS C-
TERMINAL α-9 HELIX 
2.1 Introduction 
 
The pro-apoptotic member of BCL-2 family BAX is proposed to be the main executor of 
the mitochondria, causing a perforation of mitochondrial outer membrane and release of 
apoptogenic factors (Borner 2003;Cory et al. 2003;Degenhardt et al. 2002;Gross et al. 1999). 
This cytosolic protein translocates to mitochondrial membrane upon apoptotic stimuli 
(Antonsson et al. 2001;Nechushtan et al. 2001). The structural changes involved in the transition 
from inactive cytosolic form to an active membrane bound form are not completely understood. 
Structural studies suggested that BAX undergoes conformational changes as it translocates to 
membranes. The portion of a hydrophobic C-terminal region of BAX forms α9 helix. The helix 
α9 helix must disengage from the hydrophobic groove and the α2 helix must rotate to expose the 
BH3 domain for dimerization (Suzuki et al. 2000).  However, that these are physiological events 
occurring during apoptosis has yet to be proven. Nor has conclusive evidence demonstrated how 
such conformational changes are accomplished. Diverse findings proposed regulatory 
interactions with BH3-only proteins such as BID (Ruffolo et al. 2000), BIM (Marani et al. 2002) 
or PUMA (Zhu et al. 2004), other proteins such as ACS (Ohtsuka et al. 2004), clusterin (Zhang 
et al. 2005) or Ku70 (Yoshida et al. 2004), and signaling proteins such as p53 (Chipuk et al. 
2004), AKT (Gardai et al. 2004), JNK (Tsuruta et al. 2004), 14-3-3 (Nomura et al. 2003) or 
GSK-3 (Linseman et al. 2004) with BAX.  In contrast to direct intervention by an accessory 
protein, Khaled et al. first reported that the activation of BAX coincided with a rise in 
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intracellular pH (Khaled et al. 1999), suggesting that BAX assumed a membrane-binding 
conformation in response to cytosolic alkalinization.   
Several research reports suggested that the α9 helix is a transmembrane region essential 
for membrane binding (Nechushtan et al. 1999;Schinzel et al. 2004), while others maintain that it 
is either a regulatory domain (Arokium et al. 2004)  or dispensable for apoptotic activity 
(Tremblais et al. 1999).  Hence, how the α9 helix regulates the activity of BAX remains unclear.  
Likewise, the role of the hydrophobic groove also remains speculative – though it incorporates 
the critical BH3 domain.  To better understand the function of these domains, I used 
computational modeling and targeted mutagenesis to demonstrate that the C-terminal α9 helix 
and the hydrophobic groove of BAX are both necessary for membrane association.  I observed 
that, in the presence of endogenous BAX, the α9 helix could confer membrane-binding capacity 
to a cytosolic protein.  To explain this, I propose that the α9 helix associates in reverse 
orientation with the hydrophobic pocket of adjacent BAX molecules, enabling dimerization and 
the release of additional membrane-binding domains that facilitate the insertion of BAX into 
mitochondrial membranes.   Intracellular alkalinization may facilitate this process by altering 
mitochondrial membrane dynamics. 
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2.2 Material and Methods 
2.2.1 Cell Lines and Reagents 
 
The Flp-In T-REx-293 cell line (Invitrogen) was derived from 293 human embryonic 
kidney cells(Graham et al. 1977) that stably expressed the lacZ-Zeocin fusion gene and the Tet 
repressor. The 293 cell line was maintained in D-MEM (high glucose), 10% FBS (tetracycline-
reduced) and 2 mM L-glutamine and 1% Pen-Strep.  The HCT116 BAX-/- and BAX+/+ colorectal 
cancer cell lines (from Dr. Bert Vogelstein, John Hopkins University) were maintained in 
McCoys 5A media, 10% FBS and 1% Pen-Strep. Staurosporine, Z-Vad-FMK (Calbiochem), 
nigericin (Molecular Probes), and dimethylamiloride (DMA) (Sigma) were prepared as stock 
solutions in DMSO or ethanol.  
Peptides: The C-terminal peptide of wild-type BAX (Ac-
VTIFVAGVLTASLTIWKKMG-NH2) and the BAX-leucine (BAX-LL)  mutant peptide, (Ac-
VTIFVAGVLTASLTIWLLMG-NH2) were synthesized by Biopeptide Co., (San Diego, CA) 
and were > 90% pure as confirmed by HPLC.  The HPLC-purified, BIM BH3 peptide, 
DNRPEIWIAQELRRIGDEFNAYYAR, was donated by Dr. Douglas Green, St. Jude Children’s 
Research Hospital.  Peptides were resuspended in DMSO at a stock concentration of 10mM. 
 
2.2.2 Plasmids, Mutagenesis and Transfection 
 
For inducible expression of BAX wild-type (WT) and mutant proteins, I employed the 
Flp-In T-REx System (Invitrogen). BAX WT and mutant genes were cloned into the expression 
vector, pcDNA5/FRT/TO. This expression vector undergoes recombinase-mediated DNA 
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recombination at the Flp Recombination Target (FRT) site when co-expressed with the pOG44 
plasmid that constitutively expresses the Flp recombinase. BAX constructs were amplified from 
the template, pEGFP-BAX (from Dr. Richard Youle, NINDS, NIH) with PCR, digested with 
EcoRV and cloned into pcDNA5/ FRT/TO expression vector. 
All constructs were confirmed by sequencing. The pOG44 plasmid and the 
pcDNA5/FRT/TO vectors were cotransfected into the Flp-In T-REx 293 cell line, at a ratio of 
9:1 with the Fugene 6 transfection reagent (Roche) following manufacturer’s protocol. Stable 
Flp-In T-REx expression cell lines were then selected for blasticidin resistance (10 μg/ml), 
hygromycin resistance (100 μg/ml) and zeocin sensitivity (200 μg/ml). BAX expression was 
induced by the addition of tetracycline (1 μg/ml).  
For transient, constitutive expression of BAX in HCT116 cells, pcDNA5/FRT/TO 
vectors, containing the BAX WT and mutant genes, were transfected using the TransIT-LT1 
transfection reagent (Mirus) following manufacturer’s protocol. In the absence of the Tet 
repressor, gene expression from pcDNA5/FRT/TO is constitutive. HCT116 cells were examined 
24-48 hours after transfection for apoptosis by microscopy as described below.  
PCR-directed mutagenesis of BAX was performed using HA-tagged primer sets, with 
mutations incorporated within the primer sequences (Table 2).  To generate EGFP-BAX-CT, 
EGFP fused with the C-terminus of BAX was created by PCR from the template pEGFP 
(Clontech), and the PCR insert was cloned into pcDNA5/FRT/TO as previously described. 
HCT116 cells were transiently transfected using TransIT-LT1 reagent and cells assayed for 
EGFP expression 24-48 hours later. 
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Table 3: The list of BAX mutants and primers 
 
BAX mutant Forward Primer Reverse Primer 
BAX-KK 5’-GGATCACTCTCGGCCTG 
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’ 
5’-CGTCGACTGCAGAATTCT 
CAGCCCATCTTCTTCCAGATGGTGAG
CGAGG-3’ 
BAX-ΔNT 
(1-19) 
5’-CCGGGGAGCAGCCCCATA 
TGTACCCATACGATGTTCCAGATTAC
GCTATGAAGACAGGGGCCCTTTTGC-
3 
5’-CGTCGACTGCAGAATTCT 
CAGCCCATCTTCTTCCAGATGGTGAG
CGAGG-3’ 
BAX-ΔCT 
(173-192) 
5’-GGATCACTCTCGGCCTG 
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’ 
5’-CGTCGACTGCAGAATTCT 
CAGGTCTGCCACGTGGGCGTCCCAA
AG-3’ 
BAX-LL 5’-GGATCACTCTCGGCCTG 
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’ 
5’-CGTCGACTG CAGAATTCTC 
AGCCCATGAGGAGCCAGATGGTGAG
CGAGG-3’ 
BAX-DD 5’-GGATCACTCTCGGCCTG 
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’ 
5’-CGTCGACTGCAGAATTCTC 
AGCCCATGTCGTCCCAGATGGTGAG
CGAGG-3’ 
BAX-EE 5’-GGATCACTCTCGGCCTG 
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’ 
5’-CGTCGACTGCAGAATTCTC 
AGCCCATCTCCTCCCAGATGGTGAG
CGAGG-3’ 
BAX-RR 5’-GGATCACTCTCGGCCTG 
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’ 
 
5’CGTCGATCTCAGCCCATTCGTCGCC
AGATGGTGAGCGAGG-3’ 
BAX-QQ 5’-GGATCACTCTCGGCCTG 
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’ 
5’-CGTCGACTGCAGAATTC 
TCAGCCCATCTGCTGCCAGATGGTG
AGCGAGG-3’ 
BAX-KMGK 5’-GGATCACTCTCGGCCTG 
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’ 
5’CGTCGACTGCAGAATTCTC 
ACTTCCCCATCTTCCAGATGGTGAGC
GAGG-3 
BAX-LK 5’-GGATCACTCTCGGCCTG 
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’ 
5’-CGTCGACTGCAGAATTCTC 
AGCCCATCTTGAGCCAGATGGTGAG
CGAGG-3’ 
BAX-KL 5’-GGATCACTCTCGGCCTG 
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’ 
5’-CGTCGACTGCAGAATTCTC 
AGCCCATGAGCTTCCAGATGGTGAG
CGAGG-3’ 
BAX-EK 5’-GGATCACTCTCGGCCTG 
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’ 
 
5’-CGTCGACTGCAGAATTCTC 
AGCCCATCTTCTCCCAGATGGTGAGC
GAGG-3’ 
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BAX mutant Forward Primer Reverse Primer 
BAX-KE 5’-GGATCACTCTCGGCCTG 
GACACCATGGGGATGTACCCATACG
ATGTTCCAGATTACGCTGACGGGTCC
GGGGAGCAG-3’ 
5’-CGTCGACT GCAGAATTCTC 
AGCCCATCTCCTTCCAGATGGTGAGC
GAGG-3’ 
EGFP-BAX-
CT 
5’-GGATCACTCTCGGCCTGG 
ACGAGGATATCGTCGCCACCATGGT
GAGCAAG-3 
5’-TGCAGATATCTCAGCCCAT 
CTTCTTCCAGATGGTGAGCGAGGCG
GTGAGCACTCCCGCCACAAAGATGG
TCACGGTCTGCCACGTGGGGTTATCT
AGATC-3’ 
BAX-ΔCT 
E69W 
5’-CTCAAGCGCATCGGGGACTGGCT 
GGACAGTAACATGGAG-3’ 
5’-CTCCATGTTACTGTCCAGCCAGT 
CCCCGATGCGCTTGAG-3’ 
BAX-ΔCT 
E69R 
5'-CTCAAGCGCATCGGGGACAAGC 
TGGACAGTAACATGGAG-3' 
5'-CTCCATGTTACTGTCCAGCGGGT 
CCCCGATGCGCTTGAG-3' 
 
2.2.3 Mitochondrial Translocation Assays, Crosslinking, Co-immunoprecipitation and 
Immunoblotting 
 
BAX expression was induced in 293 cells by addition of 1 μg/ml tetracycline.  EGFP-
BAX-CT or BAX-ΔCT was constitutively expressed in HCT116 cells. After 48 hours of 
induction or expression, 293 or HCT116 cells were harvested and mitochondrial and cytosolic 
protein lysates were prepared using a mitochondrial extraction kit with minor modifications 
(Pierce).  Briefly, 2 x 107 cells were lysed using the mild detergent method.  This method is 
highly reproducible and does not induce conformational changes that lead to mitochondrial 
translocation of BAX. The final mitochondrial pellet was washed in 1M NaCl to remove any 
proteins peripherally associated with mitochondria.  Mitochondrial and cytosolic protein lysates 
were loaded on 12% SDS-PAGE gels (Invitrogen), transferred to PVDF membranes and 
immunoblotted.  For detection of HA-tagged BAX, an anti-HA mouse monoclonal antibody was 
used (16B12, Covance).  For detection of endogenous BAX (N-20 Santa Cruz), prohibitin (Ab-2, 
Fitzgerald) and p38 MAPK (C20, Santa Cruz), rabbit polyclonal antibodies were used. For 
detection of EGFP (A.v. antibody, Clontech) a mouse polyclonal antibody was used. Appropriate 
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secondary rabbit or mouse antibodies crosslinked to horse radish peroxidase (HRP) (Cell 
Signaling) were used for detection.  Enhanced chemo-luminescence (Pierce) was used for 
visualization following the manufacturer’s protocol.  
Crosslinking of BAX-/- HCT116 cells, co-transfected with BAX-ΔCT and EGFP-BAX-
CT was performed using the crosslinking agent, disuccinimidyl suberate (DSS), following 
manufacturer’s protocol.  Forty-eight hours after transfection, whole HCT116 cells, after 
washing and resuspending in PBS, were treated for 30 minutes on ice with 10 mM DSS.  The 
reaction was quenched with 10 mM Tris, pH 7.4 and 100 mM glycine.  Cells were then lysed in 
mitochondrial isolation buffer (Pierce) as described above, and the cytosolic and mitochondrial 
protein fractions were combined and 2% CHAPS was added.  Protein lysates were 
immunoprecipitated with an antibody specific for an internal BAX epitope (BAX Ab-4, 
Calbiochem) and analyzed on a 12% SDS-PAGE gel.  Proteins were immunoblotted and 
detected with antibodies for EGFP as previously described.    
To examine the direct effect of apoptotic mitochondria on the translocation of BAX, 
mitochondria were isolated from 2 x 107 BAX-/- HCT116 cells using the mitochondrial extraction 
kit (Pierce).   To isolate EGFP-BAX-CT or BAX cytosolic proteins, these were expressed in 
HCT116 cells for 48 hours and cytosolic fractions were isolated from 107 cells using the 
mitochondrial extraction kit (Pierce). To determine whether EGFP-BAX-CT could translocate to 
apoptotic mitochondria, BAX-/- HCT116 cells were treated for 1 hour with 1 μM staurosporine 
or pH fixed at 7.2 or 7.8 for 20 minutes with 5 μM nigericin in a high K+ HEPES buffer (25 mM 
Hepes, 145 mM KCl, 0.8 mM MgCl2, 1.8mM CaCl2, 5.5 mM glucose).  Control, apoptotic or 
alkaline mitochondria were isolated using the mitochondrial extraction kit (Pierce).  Cytosolic-
derived EGFP-BAX-CT from HCT116 cells was incubated for 30 minutes with mitochondria at 
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37° C in a volume of 100 μl. Mitochondria were then washed 3 times in isotonic buffer 
(mitochondrial extraction kit). The final mitochondrial pellet was washed in 1 M NaCl to remove 
peripherally associated proteins.  Mitochondrial protein lysates were prepared, resolved by SDS-
PAGE and immunoblotted for BAX and prohibitin. 
To assess the effect of the BAX and BIM peptides on the mitochondrial translocation of 
BAX, cytosolic endogenous BAX or constitutively expressed BAX-ΔCT were isolated from 107 
HCT116 cells using the mitochondrial extraction kit (Pierce) and incubated with the peptides (5-
25 μM) in a volume of 100 μl for 30 minutes.  The cytosol/peptide mixture was then incubated 
for 30 minutes with neutral or alkaline mitochondria prepared as described above from 2 x 107 
BAX-/- HCT116 cells. Mitochondria were then washed, resolved by SDS-PAGE and 
immunoblotted for BAX and prohibitin as previously described. 
 
2.2.4 Triton X-114 Phase Partitioning 
 
The hydrophobicity of BAX-KK and BAX-LL was examined by Triton X-114 phase 
partitioning (Brusca, Radolf 1994;Pryde 1998). Briefly, cytosolic extracts prepared in isotonic 
buffers were treated with 2% (vol%vol) Triton X-114 (Sigma), and the hydrophobic detergent 
phase was partitioned by incubation at 37°C followed by high-speed centrifugation. Bax was 
immunoprecipitated from the detergent phase and analyzed by immunoblot, as previously 
described.  
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2.2.5 pH Assays 
 
The EGFP mutant, EYFP, exhibits pH dependent fluorescence in the pH range 6-8 
(Hanson et al. 2002;Wachter et al. 1998).  The fluorescence emission (527 nm peak) and 
excitation (514 nm peak) of EYFP decreases with decreasing pH.  HCT116 cells were 
transfected with EYFP using TransIT-LT1 reagent (Mirus) and cells were assayed for EYFP 
expression 48 hours later. To induce alkalinization, EYFP-expressing cells were treated for 30 
minutes to 1 hour with 1 µM staurosporine and changes in EYFP fluorescence were determined 
by flow cytometry   (BD-FACSCalibur; excitation 488 nm, emissions filtered through a 525 nm 
band pass (green fluorescence).  Dead cells were excluded by forward and side scatter gating.  A 
pH calibration curve was generated by incubation of EYFP-expressing cells for 30 minutes in a 
high K+ Hepes buffer (described above) at different pH values from 6.8 to 8.0 in the presence of 
the ionophore nigericin (5 μM).  Cells were immediately assayed by flow cytometry 
(FACSCalibur; Becton, Dickinson and Company). 
 
2.2.6 Confocal Microscopy 
 
HCT116 cells were grown on coverslips coated with 200 µg/ml poly-L-lysine (Sigma) 
and transfected with the EGFP-BAX-CT using the Mirus LT-1 reagent according to the 
manufacturer’s protocol. After 48 hours, apoptosis was induced with staurosporine (1 µM) or the 
cells were exposed to different pH conditions using nigericin and high K+ buffers as described 
above.  Cells were rinsed with PBS, fixed and permeabilized with ice cold methanol for 10 min 
at -200C. Cells were blocked with 1% BSA in PBS for 1 hour and stained with a primary 
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antibody HSP60 (H-300, Santa Cruz) for 45 min followed by secondary anti-rabbit IgG-Texas 
Red (Santa Cruz) for 30 min. After a final rinse, coverslips were mounted with Gel/Mount 
(Biomeda). The images were acquired by LSM 510 NLO, Carl Zeiss. 
 
2.2.7 Computational Docking 
 
The structure of BAX (PDB ID: 1F16) was obtained from the RCSB Protein Data Bank 
(http://www.rcsb.org/pdb). The primary sequences of BCL-2 proteins were obtained from 
UniProtKB (http://ca.expasy.org/uniprot).  The BAX NMR encompasses 20 models. In order to 
determine the best representative from all models, the program NMRClust (Kelley et al. 
1996a;Kelley et al. 1997) was used to cluster the structures. The best representative of the cluster 
(as determined by the most structures and the smallest RSMD for the cluster) was structure 
number 6. This structure was used in all calculations and computational manipulations.  
Computational site directed mutagenesis was performed by substituting individual residues 
of BAX α9 helix with alanine using BioMed Cache 6.1.10 program (Fujitsu America, Inc., 
Sunnyvale, CA) as the graphical user interface. MM3 force field calculations were performed 
using parameters as described (Allinger et al. 1989b;Allinger et al. 1989a;Lii, Allinger 1989;Lii, 
Allinger 1994;Lii, Allinger 1998a). Calculations were performed in vacuo, disregarding an 
explicit water/membrane environment. The energy of each molecule was calculated until 
convergence (energy minimization) was reached. Energy terms included Van der Waals, 
electrostatics and hydrogen bonding interactions. All atoms in the structure were locked; except 
protons and side chains within a distance of 5Å from the mutation site. A conjugated gradient 
was used to locate the energy minimum. Van der Waals interactions between atoms separated by 
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more than 9.0Å were excluded. Optimization continued until the energy change was less than 
0.001 kcal/mol. The estimated interaction energy (IE) was determined through separate 
calculations of the energy of the BAX structure prior the mutation (E1), and the energy of the 
BAX structure after single site mutation (E2), followed by the difference between these terms 
(IE=E2- E1). 
The peptides used in computational modeling and docking were peptides derived from BCL-
XL (UniProtKB ID: Q07817), BCL-2 (P10415), BAD (Q92934), BIM (O43521), BAK 
(Q16611) and BAX (Q07812). All peptides used in the calculations were 20 amino acids in 
length. BCL-XL BH3 peptide incorporated residues 82-101 (UniProt sequence numbering), 
BCL-2 BH3 residues 89-108, BAD BH3 residues 107-116, BAX BH3 residues 54-73, BIM BH3 
residues 146-165, and BAK BH3 residues 70-89. C-terminal peptides encompassed last 20 
amino acids of the BCL-2, BCL-XL and BAX sequence. 
The backbone of BAX α9 helix (residues 170-189) was used as a template on which 
peptides of BH3 domains and C-termini were built as alpha helices in BioMed Cache 6.1.10 
program and their energy minimized using MM3 force field calculations under parameters 
described earlier. The atoms of the backbone were locked; atoms of side chains including 
protons were unlocked. 
To perform receptor-ligand docking simulations, C-terminus of BAX (residues 170-192) 
was removed from the NMR structure to expose the hydrophobic groove. All the structures were 
submitted to the docking server GRAMM-X (Tovchigrechko, Vakser 2005a;Tovchigrechko, 
Vakser 2006a), where BAXΔ170-192 was assigned as a receptor and peptides as ligand. The 
server returned 10 different docking solutions for each receptor-ligand combination. The energy 
minimization was performed by MM3 force field calculation under parameters described earlier. 
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All atoms except protons were locked. The interaction energy (IE), was estimated through 
separate determination of the energy of the complex (Ecomplex), the complex without the peptide 
(Ecomplex w/o peptide) and peptide alone (Epeptide), and by taking the difference between these terms 
(IE=Ecomplex-(Ecomplex w/o peptide+Epeptide)). To determine the potential interaction energies for 
different helical peptides with the hydrophobic pocket, the interaction energy obtained for each 
peptide was compared with the interaction energy of BAX C-terminal peptide in the original 
(forward) orientation within the pocket using the formula (IE=IEpeptide-IEC-terminus BAX). The 
graphic images were produced by DS Viewer Pro 5.0 (Accelrys Software Inc.).   
 
2.3 Results 
2.3.1 Lys189 and Lys190 in the C-terminal α9 helix modulate the intracellular 
localization of BAX. 
 
The NMR structure of soluble, cytosolic-form of BAX shows that its C-terminal α9 helix 
is partially buried in an internal hydrophobic pocket formed by helices 2, 3, 4 and 5(Suzuki et al. 
2000). To serve as a potential transmembrane domain, the α9 helix must first disengage from the 
hydrophobic pocket.  Therefore, my first goal was to identify the residues within the α9 helix 
that mediated the binding of the helix within the hydrophobic pocket.  To begin this process, I 
performed computational site-directed mutagenesis using the NMR structure of BAX as the 
template.  For this analysis, I chose the last twenty amino acids of the α9 helix.  Each individual 
amino acid was replaced with alanine and the effects on the interaction energy were determined.  
Replacement of most of the amino acids throughout the C-terminus with alanine did not 
significantly change the interaction energy of the residue within the helix (Figure 3).  In contrast, 
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the mutation of lysine 189 resulted in dramatically altered interaction energy, primarily through a 
change in hydrogen bond energetics. This held true regardless of the orientation of the α9 helix 
within the groove. Though this simulation did not conclusively rule out a role for other residues 
within the α9 helix in the regulation of the activity of BAX, it does suggest that mutation of 
Lys189 could potentially destabilize the binding of the α9 helix with the charged residues on the 
margin of the hydrophobic pocket.  Thus, lysine 189 might function as a loose anchor of the α9 
helix through weak hydrogen bond interactions with acidic or polar residues within the 
hydrophobic pocket.  The C-terminus of BAX contains two lysine residues back-to-back, lysine 
189 and lysine 190, a unique feature among BCL-2 family members.   My next step was to 
experimentally test the conclusion determined by computational analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Summary of the computational mutagenesis of Lys189. 
Computational site-directed mutagenesis was performed using the BioMed Cache 6.1.10 suite. Individual 
residues of the BAX α9 helix (amino acids 172-189) were substituted one at the time with the alanine. The resulting 
interaction energies (IE) were determined. Substitution of Lys189 for alanine could potentially destabilize the 
interaction of C-terminal α9 helix with the charged or polar residues on the margin of the hydrophobic pocket.  IE = 
E2-E1, IE – the interaction energy, E1 – the energy of BAX before mutation, E2 – the energy of BAX after the 
mutation 
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To experimentally test the computational predictions, a series of mutagenesis 
experiments were performed targeting lysine 189 and 190 in the C-terminus of BAX.  To 
circumvent the spontaneous apoptosis caused by the toxicity of the wild-type BAX (Annis et al. 
2005;Antonsson et al. 2001;Borner 2003;Gross et al. 1999) and its construct, I applied two 
different strategies for expression in mammalian cells.  I engineered (1) HA-tagged-BAX 
mutants for the tetracycline inducible expression in a 293 cell line, which did not cause 
spontaneous apoptosis during short term induction, and (2) HA-tagged-BAX mutants which were 
co-expressed with EGFP as a marker in a BAX-/- HCT116 cell line and the absence of EGFP+ 
cells was used as a measure of spontaneous apoptosis by microscopic inspection.  I included the 
wild-type and N- or C-terminal truncated BAX mutants as controls along with the BAX 
Lys189/190 mutants. The 293 cells inducibly expressing wild-type BAX (BAX-KK) displayed a 
typical partitioning between cytosol and mitochondria.  N-terminal truncated BAX mutant 
(BAX-∆NT), lacking residues 1-19, was largely localized in mitochondria.  C-terminal truncated 
BAX (BAX-∆CT), lacking residues 173-192, was cytosolic (Figure 4).   The remaining 
immunoblots demonstrating the results achieved for other C-terminal BAX mutants are not 
shown since this work was performed by other lab technical personnel. For purposes of 
discussion, the complete results for the C-terminal mutagenesis study are summarized in Table 4.   
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Figure 4: Expression of HA-tagged BAX mutants in 293 cells. 
HA-tagged BAX mutants were inducibly expressed in 293 cells using the Flp-In T-Rex expression system. 
After 24 hours of induction with tetracycline, cells were lysed and mitochondrial and cytosolic lysates prepared. The 
presence of HA-BAX was assayed by immunoblotting with an anti-HA antibody. As controls for loading and 
subcellular fractionation, p38 MAPK was blotted for cytosolic content and Prohibitin was blotted for mitochondrial 
content. Note that loss of the two charged lysines altered the migration pattern of BAX-LL in SDS-PAGE gels. The 
mitochondrial translocation of other BAX mutants is summarized in Table 2.  
 
 
                  Table 4: Summary of BAX mutagenesis in 293 cells. 
 
 
 
 
 
 
 
 
 
Mutant Mutations of the C-terminus Primary Localization 
BAX-KK None Cyto/mito 
BAX-ΔCT Δ173-192 Cyto 
BAX-ΔNT Δ1-19 Mito 
BAX-LL K189L, K190L Mito 
BAX-DD K189D, K190D Cyto 
BAX-EE K189E, K190 Cyto 
BAX-RR K189R, K190R Mito 
BAX-QQ K189Q, K190Q Cyto/mito 
BAX-KMGK K190M, M191G, G192K Cyto/mito 
BAX-KMG ΔK190 Cyto/mito 
BAX-MGK ΔK189, K190M, M191G, G192K Cyto 
BAX-LK K189L Cyto/mito 
BAX-KL K190L Mito 
BAX-EK K189E Cyto 
BAX-KE K190E Cyto/mito 
 
The ability of BAX C-terminal mutant constructs to induce apoptosis was tested in the 
absence of endogenous BAX by co-expressing EGFP, as a marker, with BAX mutants in the 
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BAX-/- HCT116 cells.  The extent of spontaneous apoptosis was estimated by the loss of EGFP+ 
cells through fluorescent microscopic analysis. This was the best available method to document 
apoptosis, since low transfection efficiency (about 40%) and constitutive expression of the 
apoptotic forms of BAX caused rapid cell death within hours of expression, making other 
apoptotic assays (i.e. annexin staining, PI exclusion) difficult to perform.  Overexpression of 
BAX-KK and BAX-∆NT resulted in a massive spontaneous apoptosis, documented by a 
significant loss of green fluorescent, EGFP+ cells (Figure 5), and BAX-∆CT remained 
exclusively cytosolic and did not induce apoptosis as evident from the presence of EGFP+ cells 
(Figure 5).  These results agree with most other published reports (del Mar et al. 
2001;Nechushtan et al. 1999;Suzuki et al. 2000) and demonstrate that an intact C-terminus of 
BAX mediates the membrane docking step and subsequent apoptosis, while the N-terminus 
promotes cytosolic retention  In the absence of the last 20 amino acids of the C-terminus, 
encompassing the α9 helix, BAX cannot translocate to mitochondrial membranes or cause 
apoptosis in mammalian cells. 
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 Figure 5: Co-expression of HA-tagged BAX mutants with EGFP in BAX-/- HCT116 
cells. 
HA-tagged BAX mutants were constitutively co-expressed with EGFP in BAX-/- HCT116 cells. After 48 
hours, HCT116 cells were microscopically observed for loss of EGFP+ cells, indicative of apoptosis induced by co-
expression of BAX mutants.   Images shown were acquired at 40X magnification. 
 
 
Subsequent mutagenesis of lysine 189 and 190 emphasized the importance of a positive 
charge at the sites.  Substitution of lysine 189 and 190 with a negatively charged residues, 
aspartate or glutamate, resulted in complete cytosolic retention of BAX (BAX-DD, BAX-EE, 
BAX-EK) in 293 cells, and no cell death was observed in BAX-/-  HCT 116 cells (Figure 5, Table 
4).  When lysine 189 and 190 were replaced with positively charged arginine (BAX-RR), 
mitochondrial targeting and cell death resulted (Figure 5, Table 3).  The mutation of lysine 189 
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and 190 into glutamine caused predominantly a cytosolic distribution of BAX-QQ and 
intermediate toxicity as compared to BAX-KK and BAX-RR (Figure 5, Table 4).  I consistently 
found that the loss of lysine 189 confined BAX to cytosol (BAX-EK, BAX-MGK), while loss of 
lysine 190 did not have the same effect (BAX-KE, BAX-KMG, BAX-KMGK) (Figure 5, Table 
4). These results suggest that the lysine 189 is an essential mediator of BAX subcellular 
distribution.  I derive the conclusion from the mutagenesis studies that the presence of a 
positively charged residue at position 189 is necessary for the mitochondrial membrane targeting 
of BAX and the induction of spontaneous cell death, while a polar or negatively charged residue 
at this position confines BAX to the cytosol and prevents apoptosis. 
Mutations that replaced lysine 189 and/or 190 with hydrophobic leucines resulted in 
spontaneous mitochondrial targeting (BAX-LL; Figure 4) and subsequent apoptosis (BAX-LL, 
BAX-KL; Figure 5, Table 4).  The reason for this was that increasing the hydrophobic content of 
the C-terminus of BAX enhanced its membrane docking properties.  Further experimental 
evaluation of this mutant demonstrated that it partitioned into the detergent phase of preparations 
treated with Triton-114, indicative of increased hydrophobic content (Figure 6A). 
Immunoprecipitation with an N-terminal and C-terminal specific BAX antibodies (Figure 6B) 
and protease digestion (Figure 6C) further suggested that BAX-LL assumes a more relaxed 
confirmation caused by the increased hydrophobicity of the C-terminal α9 helix and subsequent 
membrane binding.  Increased pH also enhanced protease digestion as previously shown by 
Khaled et al. (Figure 6C).  The effect of pH changes on BAX will be further examined in a later 
section.  It should be noted that by substituting lysines in the C-terminus and increasing the 
hydrophobicity of this domain, the membrane binding of BAX was artificially induced in a 
manner that may not be physiological as will be further discussed.  These findings do suggest, 
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however, that manipulation of the C-terminus altered the membrane-binding activity of BAX, 
indicating its important role in this process, and an examination of how this could be achieved 
was my next step. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                            C.  
 
 
 
Figure 6: The BAX-LL mutant exhibits characteristics of an unfolded hydrophobic 
protein. 
 (A)  Mitochondrial protein lysates were prepared from 293 cells induced to express either BAX-KK (wild-
type) or BAX-LL (leucine mutant).  Lysates were treated with Triton-X-100 to separate proteins into those that 
partitioned into an aqueous phase (A) and those that partitioned into a detergent phase (D).  Proteins were assayed 
by SDS-PAGE and immunoblotted for the HA-tagged BAX protein using an anti-HA antibody (Covance).  
Compared to BAX-KK, more BAX-LL partitioned into the detergent (D) phase.  (B)  Cytosolic or mitochondrial 
protein lysates were prepared from 293 cells induced to express either BAX-KK (wild-type) or BAX-LL (leucine 
mutant).   Lysates were immunoprecipitated with an N-terminal specific BAX antibody (N-20, Santa Cruz) or a C-
terminal specific BAX antibody (ID3, Abcam).  Immunoprecipitates were washed and assayed by SDS-PAGE and 
the HA-tagged BAX protein immunoblotted using an anti-HA antibody (Covance).  The N-terminal epitope specific 
BAX antibody immunoprecipitated some cytosolic BAX but much more mitochondrial BAX, especially from cells 
expressing the BAX-LL mutant.  In contrast the C-terminal epitope specific antibody did not immunoprecipitate 
cytosolic BAX, but could immunoprecipitate mitochondrial BAX from cells expressing either BAX-LL or BAX-
KK.  The * indicates non-specific bands. (C)  Mitochondrial protein lysates were prepared from 293 cells induced to 
express either BAX-KK or BAX-LL.  Lysates were treated with proteinase K, 0-10g/ml, in isotonic buffers at pH 7, 
7.5 or 7.8.  The BAX-LL mutant was more sensitive to protease digestion than BAX-KK at neutral pH, while both 
BAX proteins were digested at alkaline pH.  This suggests that the BAX-LL mutant is more unfolded than the wild 
type protein and that alkaline pH further unfolds the protein. 
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2.3.2 The C-terminal α9 helix of BAX directs EGFP to apoptotic mitochondria 
 
The previous studies demonstrated that Lys189/190 critically regulated the subcellular 
partitioning of BAX – positive charge at the positions 189/190 directing BAX to mitochondria, 
negative or polar charge retaining BAX in the cytosol.  I next determined whether the C-terminus 
alone is able to direct a cytosolic protein to mitochondria.  To test this, I engineered a fusion 
protein EGFP-BAX-CT by attaching the C-terminus of BAX (25 amino acids) to EGFP and 
evaluating its subcellular distribution in non-apoptotic and apoptotic cells.  In my initial 
experiments, I fused only the last 20 amino acids of BAX to EGFP and did not achieve results of 
any significance.  A possible explanation is that when the C-terminus of BAX is directly attached 
to a protein it requires the presence of a putative hinge region (Schinzel et al. 2004), containing a 
proline, in order to provide the flexibility required for protein:protein interactions.  Also I did not 
express full length, wild-type BAX in this context since recall that the constitutive expression of 
BAX-KK is extremely toxic, hence the reason for using the fusion protein to study the C-
terminus of BAX.  
Using confocal microscopy, I visually inspected the distribution of EGFP-BAX-CT 
(green fluorescence) in BAX+/+ HCT116 cells for either a diffuse staining pattern, suggestive of 
cytosolic localization, or a punctate staining, suggestive of membrane binding, upon induction of 
apoptosis by staurosporine (Figure 7B). Staurosporine was chosen as the lethal insult since it is a 
well-recognized method of inducing rapid apoptosis (Kuwana et al. 2005).   I did not observe 
that the addition of the C-terminal of BAX to EGFP resulted in significant spontaneous 
membrane binding in non-apoptotic cells as had been previously reported (Schinzel et al. 2004).  
In healthy cells there were only minor differences in the staining patterns between cells 
 32
expressing cytosolic EGFP and EGFP-BAX-CT, with the latter showing more membrane 
association (Figure 7B).  The drastic difference in the staining patterns between cells expressing 
cytosolic EGFP and EGFP-BAX-CT occurred upon induction of apoptosis by staurosporine.  A 
distinctive punctate staining pattern, hallmark of membrane binding, was observed in apoptotic 
cells expressing EGFP-BAX-CT.  This staining pattern significantly overlaid (yellow 
fluorescence) with the mitochondrial marker, HSP60 (red fluorescence), demonstrating that 
fusion of the last 25 amino acids of BAX to EGFP conferred membrane binding to EGFP, but 
preferentially in apoptotic cells.   It was evident from these findings that the apoptotic 
environment promotes the translocation of EGFP-BAX-CT from the cytosol to the mitochondrial 
membrane.  EGFP-BAX-CT thus mimicked the apoptotic behavior of BAX. 
The mitochondrial co-localization studies were confirmed by immunoblotting 
mitochondria for EGFP. I obtained mitochondrial fractions from healthy or apoptotic 
mitochondria of BAX-/- HCT116 cells.  Apoptosis was induced by staurosporine.  Another set of 
HCT 116 cells, BAX+/+ and BAX-/-, was transfected with EGFP-BAX-CT.  I extracted cytosolic 
fractions from the cells.  In the final step I incubated the healthy or apoptotic mitochondria with 
the cytosol containing EGFP-BAX-CT.  Analysis by immunoblotting showed that more EGFP-
BAX-CT inserted into apoptotic mitochondria compared to healthy mitochondria (Figure 7A). 
The ratio of EGFP/prohibitin increased two-fold (BAX-/- HCT116 cells) and four-fold (BAX+/+ 
HCT116 cells) in apoptotic cells, indicating that endogenous BAX contributed significantly to 
the translocation of the EGFP-BAX-CT.  Note that EGFP-BAX-CT itself was not exposed to the 
apoptotic environment; hence the translocation of EGFP-BAX-CT to mitochondria had to be 
caused by the apoptotic mitochondria. The results also suggest while the last 25 residues of BAX 
 33
can confer mitochondrial targeting to EGFP, this is greatly enhanced in the presence of 
endogenous BAX. 
 
Figure 7: EGFP tagged with C-terminus of BAX confers mitochondrial membrane-
binding properties in apoptotic cells.   
(A) BAX-/- HCT116 cells were treated with or without 1 μM staurosporine for 1 hour and mitochondria 
harvested. Another set of BAX-/- or BAX+/+ HCT116 cells were transfected with EGFP-BAX-CT and, after 48 
hours, cells were lysed and the cytosol was incubated with non-apoptotic or apoptotic mitochondria in a test tube for 
20 min. Mitochondria were than washed several times with 1M NaCl to remove peripherally associated proteins. 
Mitochondrial protein content was analyzed by SDS-PAGE and immunoblotted with an anti-EGFP antibody and an 
anti-Prohibitin antibody as a mitochondrial loading control.  (B) BAX+/+ HCT116 cells were transfected with EGFP 
or EGFP-BAX-CT and cells assessed for EGFP expression (green) by confocal microscopy. Mitochondria were 
identifies by staining with anti-HSP60 antibody followed by a rhodamine-labeled (red) secondary antibody. 
Apoptosis was induced by treatment with 1μM staurosporine for 1 hour. Diffuse cytosolic staining pattern was 
observed in all non-apoptotic cells or cells expressing EGFP, while in apoptotic cells that expressed EGFP-BAX-CT 
a punctate staining pattern was detected that largely overlaid with mitochondria (indicated by arrows). 
 
To confirm that endogenous BAX was contributing to the binding of EGFP-BAX-CT to 
mitochondria, we repeated the expression of EGFP-BAX-CT in BAX-/- cells and did not observe 
the same degree of mitochondrial translocation that was evident when EGFP-CT-BAX was 
expressed in BAX+/+ cells    (Figure 8). 
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Figure 8: EGFP tagged with C-terminus of BAX does not confers mitochondrial 
membrane-binding properties in cells lacking endogenous BAX.  
BAX-/- HCT116 cells were transfected with EGFP or EGFP-BAX-CT and cells assessed for EGFP 
expression (green) by confocal microscopy. Mitochondria were identifies by staining with anti-HSP60 antibody 
followed by a rhodamine-labeled (red) secondary antibody. Apoptosis was induced by treatment with 1μM 
staurosporine for 1 hour. Diffuse cytosolic staining pattern was observed in all non-apoptotic cells expressing EGFP 
or EGFP-BAX-CT. In apoptotic cells that expressed EGFP-BAX-CT a minimal mitochondrial overlay was detected 
(note lack of yellow overlay compared to Figure 6B). 
 
 
 
These studies strongly indicated that the presence of endogenous BAX influenced the 
distribution of the fusion protein, EGFP-BAX-CT. To determine whether EGFP-BAX-CT could 
be in physical association with endogenous BAX, I performed a protein cross-linking 
experiment. I co-expressed the non-apoptotic form of BAX (BAX-∆CT) with EGFP-BAX-CT in 
BAX-/- HCT116 cells (Figure 8).  The intense band of cross-linked EGFP-BAX-CT heterodimers 
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at ≥64 kDa was more pronounced than the weak band of EGFP-BAX-CT monomers at 36 kDa. 
This indicated that almost all detectable EGFP-BAX-CT could be cross-linked and co-
immunoprecipitated with BAX-∆CT.  Furthermore, this result strongly suggested that EGFP-
BAX-CT and BAX-∆CT were in physical association in heterodimeric complexes. This was not 
the case with EGFP and BAX-∆CT (Figure 8).  Note that this experiment was not performed in 
the presence of either constitutively expressed wild-type BAX, because of its toxicity, or non-
apoptotic endogenous BAX, since it would not have undergone apoptotic conformational 
changes.  The summary of my results suggests that the C-terminus of BAX attached to EGFP can 
bind to structural elements exposed in the C-terminal deleted form of BAX-∆CT and form 
heterodimeric complexes that have the ability to integrate into the mitochondrial membrane.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: EGFP-BAX-CT forms heterodimers with BAX-∆CT. 
BAX-/- HCT116 cells were transiently co-transfected with EGFP or EGFP-BAX-CT and BAXΔCT. After 
24 hours, cells were treated with or without the crosslinker (DSS), lysed and combined cytosolic/mithochondrial 
proteins lysates prepared. Protein lysates were immunoprecipitated with BAX antibody (rabbit polyclonal, Ab-4), 
specific to an internal epitope. Immunoprecipitates were analyzed by SDS-PAGE and blotted for EGFP with anti-
EGFP antibody (mouse monoclonal). EGFP-BAX-CT/BAXΔCT dimers (approximately 64 kDA) were detected in 
crosslinked samples from cells in which EGFP-BAX-CT and BAX-ΔCT were co-expressed. The* indicates non-
specific bands, the most prominent being the heavy chain of immunoglobulins. 
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2.3.3 Intracellular Localization of BAX Controlled by α9 helix   
 
Based on previous observations, I next wanted to examine the binding of the C-terminus 
of BAX to structural elements within BAX itself.  Based on the NMR structure (Suzuki et al. 
2000),  I knew that the C-terminus of BAX, encompassing α9 helix, self-associates in forward 
directional orientation within the hydrophobic pocket.  The association of the BH3 peptides 
derived from BH3-only proteins BIM (Liu et al. 2003), BAD (Petros et al. 2000) and BAK 
(Sattler et al. 1997) with BCL-XL deciphered by structural studies demonstrated that those 
peptides associate with the hydrophobic pocket of BCL-XL in a reversed directional orientation.  
Such findings suggest that occupation of the hydrophobic pocket plays a major role in the 
regulation of the intracellular distribution of BCL-2 family members.  To explore this possibility, 
I used a computational approach, employing the docking web server GRAMM-X 
(Tovchigrechko, Vakser 2005b;Tovchigrechko, Vakser 2006b), in order to determine where on 
the surface of BAX would the α9 helix preferentially bind.  The underlying concept for this 
approach was that BAX would be computationally treated like a receptor and the C-terminal α9 
helix would be its ligand. 
We submitted the C-terminus-truncated structure of BAX (based on the NMR structure 
(Suzuki et al. 2000)) and the structure of the C-terminal α9 helix for testing.  By truncating the 
C-terminus, I mimicked a form of BAX with an unoccupied hydrophobic pocket, which could 
occur also upon exposure of the α9 helix during apoptosis.  Figure 9A represents the overlay of 
10 docking solutions resolved by GRAMM-X.  It is evident from my results that the α9 helix of 
BAX fits predominantly within the hydrophobic pocket. This implies that the association of the 
α9 helix with the hydrophobic pocket is energetically the most favorable location for interaction. 
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In the next step I resolved the individual docking solutions. As shown in Figure 9B, the soluble, 
cytosolic form of BAX emerged.  The α9 helix was bound into the hydrophobic pocket in the 
forward orientation, characteristic of the self-associated form, but surprisingly this forward 
orientation of binding was not the most energetically favorable docking solution.  The reverse 
orientation of binding was the most energetically favorable (Figure 9C). In this reverse 
orientation lysine 189 of the α9 helix is in binding proximity to the acidic residue glutamate 69, 
a conserved site in the α2 helix, and asparagine 73, in the hinge between the α2 and α3 helices.  
Both these residues are found within the BH3 domain of BAX.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: The helical C-terminus of BAX associates with the hydrophobic pocket of 
BAX in two orientations.   
(A) Overlay of 10 docking solutions derived from the GRAMM-X docking software for the binding of the 
α9 helix on the surface of BAXΔCT. The α9 helix binds predominantly within the hydrophobic pocket formed by 
helices 2,3,4 and 5. (B) The forward binding model of the soluble form of BAX results when the hydrophobic 
pocket is occupied by its own C-terminal α9 helix – the helix is bound in the pocket in the forward orientation and 
Lys189 is solvent exposed. (C) The more energetically favorable reverse binding model results when the C-terminal 
α9 helix binds in reverse orientation in the hydrophobic pocket of BAX. In this orientation, the Lys189 is in binding 
proximity to Glu69, a conserved site and Asp73 (not shown) within the BH3 domain.  
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 In order to establish the validity of the computational docking analysis, I compared the 
outcome of these findings with other potential binding partners of BAX.  Using the same 
methods, I estimated the binding energies which resulted from interactions between the BH3 
peptides of BIM, BAD, BAX and BAK with the hydrophobic pocket.  A number of published 
findings support such interactions (Bouillet, Strasser 2002;Cosulich et al. 1997;Kuwana et al. 
2005;Shangary, Johnson 2002;Simonen et al. 1997).  The results of the computations are 
summarized in Table 4.  Negative numbers indicate more favorable binding energies, while 
positive numbers indicate less favorable binding energies.  The binding energies of different 
BH3 helices, which were docked in more energetically favorable reverse directional orientation, 
were compared to the α9 helix of BAX bound in the forward orientation that occurs during self-
association.  The results of computational docking suggested that most BH3 domains of the 
BCL-2 family members, including that of BAX itself, would not bind to the hydrophobic pocket 
of BAX because of the unfavorable interaction energy (Table 5), suggesting that BH3 
interactions are not the primary mode through which these proteins could heterodimerize.  The 
only exception was that of the BH3 domain of BCL-2 (Table 5) that I did observe could co-
immunoprecipitate (not shown) and therefore interact with BAX.  The interaction between BAX 
and BCL-2, but not for example the interaction between BAX and BAD or BAX and BIM, is 
also supported by findings in the literature (Kuwana et al. 2005;Shangary, Johnson 
2002;Simonen et al. 1997). 
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Table 5: Analysis of BH3 peptides docked into the hydrophobic pocket of BAX. 
IE represents the difference in the binding energy between the complex, where the peptide is docked in the 
reverse orientation, and the complex, where the C-terminal of BAX is docked in forward orientation: IE =IEpeptide-
IEC-terminus BAX. 
 
Peptide Sequence IE (kcal/mol) 
CT BAX-KK VTIFVAGVLTASLTIWKKMG -52.0 
BAK BH3 QDASTKKLSECLKRIGDELD 420.8 
BAX BH3 ASTKKLSECLKRIGDELDSN 707.2 
BAD BH3 QRYGRELRRMSDEFVDSFKK 375.4 
BIM BH3 IWIAQELRRIGDEFNAYYAR 267.1 
BCL-XL BH3 PMAAVKQALREAGDEFELRY 259.0 
BCL-2 BH3 VPPVVHLTLRQAGDDFSRRY -7.7 
 
 
I observed that BAX could not interact with another BAX molecule through its BH3 
domains (Table 5).  However, hypothetically, BCL-XL could interact with the hydrophobic 
pocket of BAX via its C-terminal end.  Therefore, I used computational docking to evaluate the 
possibility that C-terminal helices, rather than BH3 domains, interacted with the hydrophobic 
groove.   Additionally, I also examined how different BAX C-terminal Lys189/190 mutants 
bound in the reverse orientation within the hydrophobic pocket of BAX.  Table 5 presents 
calculations derived from comparing the helical C-terminus of wild-type BAX, bound in the 
forward orientation to the hydrophobic pocket, to the binding of the α9 helices of BCL-XL, 
BCL-2 and a wild-type or C-terminal mutant of BAX bond in the more energetically favorable 
(negative ΔIE) reverse orientation. Note that the C-terminus of BCL-XL bound favorably within 
the hydrophobic pocket, and that his observation is supported by previously published data 
showing that BCL-XL can directly interact with BAX-∆CT (Hsu et al. 1997). 
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Table 6: Analysis of C-terminal peptides docked into the hydrophobic pocket of BAX. 
IE represents the difference in the binding energy between the complex, where the peptide is docked in the 
reverse orientation, and the complex, where the C-terminal of BAX is docked in forward orientation: IE =IEpeptide-
IEC-terminus BAX. * - See Table 2  
 
Peptide Sequence ∆IE (kcal/mol) Membrane 
Binding* 
CT BAX-KK VTIFVAGVLTASLTIWKKMG -52.0 Yes 
CT BCL-XL FLTGMTVAGVVLLGSLFSRK -134.0 Yes 
CT BCL-2 LLSLALVGACITLGAYLGHK 53.6 Yes 
CT BAX-DD VTIFVAGVLTASLTIWDDMG 223.1 No 
CT BAX-EE VTIFVAGVLTASLTIWEEMG 103.3 No 
CT BAX-QQ VTIFVAGVLTASLTIWQQMG 11.8 No 
CT BAX-RR VTIFVAGVLTASLTIWRRMG -75.1 Yes 
CT BAX-LL VTIFVAGVLTASLTIWLLMG 51.0 Yes 
 
Those Lys 189/190 mutations (Table 6) which did not cause spontaneous apoptosis had 
unfavorable binding energies (positive ΔIE) within the hydrophobic pocket (negatively charged 
residues).  While those Lys 189/190 mutations which did cause spontaneous apoptosis had 
favorable binding energies within the hydrophobic pocket (positively charged residues).  The 
only exception was a leucine 189/190 mutant, which showed unfavorable energy of binding 
within the hydrophobic pocket (Table 6) but caused significant spontaneous apoptosis (Figure 5), 
likely due to the increase in the hydrophobic content achieved because of the replacement with 
leucines (Figure 7).  The computational docking analysis suggested a mechanism that would 
explain the results of my mutagenesis studies (Table 4) and EGFP-BAX-CT expression studies 
(Figure 7).  The binding of the α9 helix within the hydrophobic pocket seems to be modulated by 
lysine 189 and 190.  In the forward orientation, Lys 189 and 190 interact with the margin of the 
hydrophobic groove and are partially solvent exposed.  In the reverse orientation, Lys 189 and 
190 interact with multiple residues within the hydrophobic groove.  In this manner, Lys 189 and 
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190 may regulate the membrane-binding activity of BAX, disputing a sole role for the α9 helix 
as a transmembrane anchor.  
 
2.3.4 Occupancy of the hydrophobic pocket by the α9 helix mediates the translocation of 
BAX to membranes. 
 
We next wanted to determine whether the more energetically favorable binding of the α9 
helix in the reverse orientation to the hydrophobic pocket caused the displacement of the α9 helix 
bound in forward orientation (as it occurs during self-association within BAX to retain the 
soluble, cytosolic form) in order to promote the mitochondrial association of the protein. To 
investigate this possibility, a peptide that incorporated last 20 residues of BAX (C-terminal α9 
helix) was commercially synthesized.  This peptide did not include the “hinge region” since it 
was not tethered to a protein (as in EGFP-CT-BAX) but was a free, soluble peptide.  I isolated 
the cytosol containing endogenous BAX from BAX+/+ HCT116 cells and added the BAX C-
terminal peptide. After a short incubation, this mixture was added to the mitochondria enriched 
from BAX-/- HCT116 cells. Analysis of the samples by immunoblotting showed that under these 
cell-free conditions BAX integrated into mitochondrial membranes only when preincubated with 
the free BAX C-terminal peptide. In addition, I overexpressed BAX-∆CT in BAX-/- HCT116 
cells.  Recall that this mutant does not induce spontaneous apoptosis (Figure 5) or translocates to 
the mitochondria (Table 3).  When I incubated the cytosol of these cells with the BAX C-
terminal peptide, BAX-∆CT now associated strongly with the mitochondria despite the lack of 
its own α9 helix. These results implied that the truncated version of BAX had higher affinity 
toward to the BAX C-terminal peptide and that the BAX C-terminal peptide bound to the 
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hydrophobic pocket of BAX molecules in a manner that leads to the exposure of other membrane 
binding domains (e.g. a transmembrane region formed by the α5, α6 helices as will be 
discussed).   
 
 
 
 
Figure 11: BAX C-terminal peptide, not BIM BH3 peptide, induces the translocation of 
wild-type and C-terminally truncated BAX. 
Cytosol (isolated in buffer at pH 7.0) was harvested from BAX-/- HCT116 cells transfected with BAXΔCT. 
The cytosol was incubated for 30 min with 25 µM of BAX α9 peptide (20-mer) or a BIM BH3 peptide (25-mer). 
The cytosol was then incubated with mitochondria, isolated from BAX-/- HCT116 cells (in buffer at pH 7.0) for 20 
min, and mitochondria were washed several times with 1M NaCl to remove peripherally associated proteins. 
Mitochondrial proteins content was analyzed by SDS-PAGE and immunoblotted with an anti-BAX antibody and an 
anti-Prohibitin antibody as a mitochondrial loading control. 
 
Having determined the effect of the BAX C-terminal peptide upon the membrane binding 
of BAX, I next examined a BH3 peptide derived from BIM.  Such BH3 peptides have been 
routinely used in experiments with artificial lipid vesicles and isolated mitochondria to show the 
effect of these peptides upon membrane insertion (Kuwana et al. 2005).  Using the same 
experiment as described earlier, I demonstrated that the BH3 peptide of BIM did not cause the 
mitochondrial translocation of BAX or BAX-∆CT (Figure 10). This observation coincided with 
the results obtained by computational docking, which indicated that the BH3 peptide of BIM 
does not interact with the hydrophobic pocket of BAX in an energetically favorable manner 
(Table 6). Next, I wanted to test if the computational docking predictions also held true for the 
BAX-LL mutant. This mutant is highly toxic, and it spontaneously translocated to the 
mitochondrial membrane, causing apoptosis (Table 4, Figure 5).  
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Figure 12: BAX-∆CT does not insert into mitochondrial membrane upon addition of 
BAX-LL peptide. 
Cytosol (isolated in buffer at pH 7.0) was harvested from BAX-/- HCT116 cells transfected with BAX-ΔCT. 
The cytosol was incubated for 30 min with 25 µM of BAX α9 peptide (20-mer) or a BAX α9 peptide in which 
Lys189/190 were mutated to leucines (BAX-LL, 20-mer). The cytosol was then incubated with mitochondria, 
isolated from BAX-/- HCT116 cells (in buffer at pH 7.0) for 20 min, and mitochondria were washed several times 
with 1M NaCl to remove peripherally associated proteins. Mitochondrial proteins content was analyzed by SDS-
PAGE and immunoblotted with an anti-BAX antibody and an anti-Prohibitin antibody as a mitochondrial loading 
control. 
 
The computational docking results implied that this mutant would not bind to the 
hydrophobic pocket due to unfavorable binding energy.  I repeated the experiment described 
above, only this time I used a BAX C-terminal peptide in which lysine 189 and 190 were both 
replaced by leucines. Even in the case of the truncated version of BAX (BAX-∆CT), the leucine 
mutant peptide did not cause the mitochondrial insertion of BAX-∆CT.  Hence, charged residues 
located at positions 189/190 are essential for the BAX C-terminal peptide to promote the 
mitochondrial integration of the protein.   To explain our earlier results with BAX-LL (Figures 4, 
5 and Table 4), recall that these involved expression of the full-length BAX mutant protein, 
enabling it to translocate to membranes because of the increased hydrophobicity of the C-
terminus.  But these results did not suggest that increased hydrophobicity was the physiological 
mechanism by which BAX normally moves to mitochondria.   
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Computational docking implied that binding of the α9 helix in reverse into the 
hydrophobic pocket occurs because of the presence of a positive charge at residue 69 (glutamate) 
within the BH3 domain, suggesting that Lys 189 and Glu 69 could interact.  In addition, a 
residue in the hinge between the α2 and α3 helices, Asn73, could also interact with Lys 189.  I 
performed computational site-directed mutagenesis of Glu 69 with different amino acids.  A 
preliminary assumption would be that the mutation of Glu 69 into an amino acid with a positive 
charge (e.g., lysine) would “repel” the incoming α9 helix.  Simply two positive positioned 
lysines back-to-back at the far end of its C-terminus could prevent any further conformational 
changes of BAX and thus inhibit its incorporation in the mitochondrial membrane and 
consequently apoptosis.  However, computational mutagenesis suggested that the mutation of 
glutamate 69 to lysine or arginine would actually results in a stronger binding of the α9 helix 
within the hydrophobic pocket in the forward directional orientation as it occurs during the self-
association (Table 5). This could prevent the release of the self-associated α9 helix to expose the 
hydrophobic groove.  Mutation of Glu 69 to aspartate would make the BH3 domain more “BCL-
2/BCL-XL like” (Table 7), resulting in the destabilization of the binding of α9 helix in the 
forward orientation and probably result in faster release of the self-associated α9 helix 
independent of apoptotic stimuli. Because of this information, I opted to mutate Glu69 in BAX-
ΔCT and not in full-length BAX. The alternation of this conserved residue could affect the self-
association of the C-terminus, creating a more toxic form of BAX or nonfunctional BAX. The 
results of the mutations Glu69Arg and Asn73Arg are presented in the Figure 13. The 
mitochondrial targeting mediated by BAX C-terminal peptide was impeded when Glu69 was 
exchanged for positively charged Arg.  This impediment of the BAX peptide-induce 
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mitochondrial translocation was further increased upon double mutation, in which the conserved 
Glu69 was exchanged for positive Arg and Asn73 to Arg.  These results significantly strengthen 
the conclusion that the reverse orientation of binding of α9 helix to the hydrophobic pocket 
regulates the mitochondrial integration of BAX and that this involves interactions between the 
charged residues, Lys 189/190, in the α9 helix, and Glu69/Asn73 within the hydrophobic pocket, 
confirming computational predictions.  
Our computational and experimental results led us to the conclusion, that the C-terminus 
of BAX (encompassing α9 helix) might function as a membrane anchor, but more importantly, it 
is most essential for promoting the apoptosis by interacting in reverse orientation with the 
hydrophobic pocket of adjacent BAX molecule, forming dimers and inducing conformational 
changes that expose additional transmembrane domains, leading to mitochondrial integration. 
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Table 7: Summary of the computational mutations of conserved glutamate 69. 
IE represents the difference in the binding energy between the α9 helix and the hydrophobic pocket after 
the mutation and before the mutation of Glu69. IE =E2-E1, IE – the interaction energy, E1 – the energy before 
mutation, E2 – the energy after mutation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutation Electrostatics 
(kcal/mol) 
Hydrogen bond 
(kcal/mol) 
Van der Waals  
(kcal/mol) 
IE 
(kcal/mol) 
E69A 388.5 -35.9 5.9 -95.2 
E69R 307.0 -37.1 17.3 -158.8 
E69N 379.2 -6.5 -0.4 -87.2 
E69D 446.7 13.3 3.7 24.0 
E69C 399.4 -35.8 6.8 -82.3 
E69Q 364.4 -49.2 6.8 -143.5 
E69G 391.7 -20.3 2.2 -80.9 
E69H 390.7 -38.1 10.4 -57.1 
E69I 386.4 -40.8 8.8 -103.0 
E69L 389.3 -39.6 19.3 -78.5 
E69K 307.5 -136.9 -2.3 -319.2 
E69M 380.3 -41.2 6.5 116.5 
E69F 396.6 -15.8 13.6 -47.3 
E69P 655.9 -25.8 27.2 -16.8 
E69S 401.1 -48.7 7.4 -99.8 
E69T 399.5 -8.6 22.7 -12.2 
E69W 392.2 -2.4 14.8 -45.7 
E69Y 392.2 -2.4 14.8 -46.7 
E69V 389.1 -35.8 7.8 -89.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: BAX-∆CT R69R73 does not insert into mitochondrial membrane upon 
addition of BAX- peptide. 
Cytosol (isolated in buffer at pH 7.0) was harvested from BAX-/- HCT116 cells transfected with BAX-ΔCT 
E69N73, BAX-ΔCT R69N73 and BAX-ΔCT R69R73. The cytosol was incubated for 30 min with 25 µM of BAX 
α9 peptide (20-mer) or a mutant BAX α9 peptide in which Lys189/190 were mutated to leucines (BAX-LL, 20-
mer). The cytosol was then incubated with mitochondria, isolated from BAX-/- HCT116 cells (in buffer at pH 7.0) 
for 20 min, and mitochondria were washed several times with 1M NaCl to remove peripherally associated proteins. 
Mitochondrial proteins content was analyzed by SDS-PAGE and immunoblotted with an anti-BAX antibody and an 
anti-Prohibitin antibody as a mitochondrial loading control. 
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2.3.5 BAX responds on the changes in pH.  
 
My results in the previous sections established that lysine 189 and 190 are important 
mediators of intracellular localization of BAX, promoting mitochondrial membrane binding.  
Based on these observations I wanted to study possible physiological processes that could be 
involved in facilitating the movement of BAX to membranes.  Previous work by Khaled et al. 
demonstrated that changes in the intracellular pH are common features in the cytokine dependent 
cell lines (Khaled et al. 1999).  Briefly, during death induced by cytokine withdrawal in an IL-7-
dependent pro-T cell line (D1) or an IL-3-dependent pro-B cell line (FL5.12A), there was a 
transient rise of intracellular pH above 7.8 several hours after cytokine removal. This rise in pH 
coincided with the translocation of BAX to mitochondria.  Treatment with inhibitors of the 
sodium-hydrogen exchanger (NHE) or p38 MAP kinase inhibited alkalinization inhibited the 
alkalinization process, indicating that these proteins were involved in mediating the change in 
intracellular pH (Khaled et al. 1999).  I observed that this same transient alkalinization also 
occurred in BAX+/+ or BAX-/- HCT116 cells within 30 minutes to one hour of staurosporine 
treatment (Figure 13A). Intracellular pH changes were measured by detecting the pH-sensitive 
changes in EYFP fluorescence. Engineered mutants of EGFP that exhibit pH-dependent 
absorbance and fluorescence emission properties are commonly used for the measurement of pH 
changes within cells and cell organelles (Demaurex 2002;Llopis et al. 1998;Matsuyama et al. 
2000;Wachter et al. 1998). Furthermore, Khaled et al. previously observed that BAX 
translocation to the mitochondria could be controlled by manipulating pH levels (Khaled et al. 
1999).  A similar experiment is shown in Figure 14B. The translocation of BAX was regulated 
by inducing or inhibiting alkalinization.  Intracellular pH in staurosporine-treated BAX+/+ 
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HCT116 cells was fixed at pH 7.2 with the ionophore, nigericin, in high K+ buffers,  preventing 
the mitochondrial translocation of BAX.  These results indicated that changes in cytosolic pH 
could affect the movement of BAX to the mitochondria.  I observed that the rise in pH could 
induce the translocation of BAX and neutral pH could prevent it.  
 
A. B.
 
 
 
Figure 14: The intracellular distribution of BAX depends on pH. 
(A) BAX-/- or BAX +/- HCT116 cells, expressing pH-sensitive deYFP vector, were treated for 1 hour with 
1µM staurosporine and intracellular pH measures by detecting changes in the EYFP fluorsence by flow cytometry 
against a previously established calibration curve. Staurosporine treatment induced a transient alkalinization that is 
independent of the presence of BAX. (B) BAX+/+ HCT116 cells were cultured with or without 1µM staurosporine 
and permeabilized with 1 µM nigericin in a high K+ buffer at pH 7.2 or 7.8 for 30 min. Mitochondrial lysates were 
prepared and BAX and Prohibitin (mitochondrial loading control) assayed by immunoblotting. Alkaline pH induces 
the mitochondrial translocation of BAX, while neutral pH prevents it. The ratio of BAX to the control protein 
Prohibitin was determined by densitometer. 
 
2.3.6 Alkalinization Alters Mitochondrial Physiology 
 
BAX translocates to the mitochondrial membrane during apoptosis or upon exposure to 
alkaline pH in healthy cells.  The question is: how does alkaline pH mediate the translocation of 
BAX to mitochondrial membranes? Alkalinization may disrupt weak hydrogen bond interaction 
between the C-terminal lysine 189 in the α9 helix when it is bound in the forward orientation 
within the hydrophobic pocket, leading to local conformational changes which destabilize the 
helix, exposing the hydrophobic pocket.  This could also be initiated by the presence of lipid 
membranes (Yethon et al. 2003).  My experiments performing targeted mutagenesis of lysine 
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189 and 190 could not mimic the subtle effects that intracellular alkaline pH could have on 
hydrogen bond interactions.  However, the observation that an intact positive charge at position 
189 was required for apoptotic activity (Table 5) indicated that a positive charge at the distal end 
of the C-terminus is required for the membrane association. Thus an alternative explanation is 
that alkalinization may have a more pronounced effect by disrupting membrane dynamics and 
facilitating the insertion of BAX.  To explore this possibility, I designed experiments to 
determine whether the affinity of mitochondria toward BAX changed with pH. 
Because previous experiments showed that intracellular pH rises within 30 minutes to 1 
hour after the staurosporine treatment, I wanted to determine if EGFP-BAX-CT responded to 
mitochondrial changes caused differences in pH. A similar experiment was performed with 
apoptotic mitochondria and showed that apoptotic mitochondria attracted more BAX (Figure 
7A).  To examine pH-dependent effects, I used non-apoptotic mitochondria from BAX-/- 
HCT116 cells, which were exposed to conditions that equilibrated intracellular pH at 7.2 and 7.8.  
The equilibration of intracellular pH was achieved by exposing BAX-/- HCT116 cells to high K+ 
buffer at pH 7.2 or 7.8 with the potassium ionophore, nigericin.  The isolated mitochondria were 
then incubated with cytosol from BAX+/+ HCT116 cells transfected with EGFP-BAX-CT.  The 
results showed that EGFP-BAX-CT preferentially associated with mitochondria exposed to an 
alkaline environment (Figure 15).   
To confirm this finding, I inspected the ability of EGFP-BAX-CT to associate with 
mitochondria in alkalinized cells in experiments similar to ones performed with staurosporine to 
induce apoptosis (Figure 8).  As was shown in Figure 14A, alkalinization occurs as a result of 
staurosporine treatment.  EGFP-BAX-CT was mostly diffused throughout the cytosol of BAX+/+ 
HCT116 cells equilibrated at pH 7.2, while cells at pH 7.8, a pronounced punctuate pattern was 
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observed (Figure 15A). The staining overlaid with mitochondria marker HSP60, suggesting that 
the attachment of the last 25 amino acids of BAX C-terminus to EGFP conferred mitochondrial 
membrane binding upon intracellular alkalinization.  In BAX+/+ cells exposed to pH 7.2 as a 
control also indicated a small amount of mitochondrial overlay. This was expected because the 
C-terminus of BAX enabled some tagged EGFP to bind to mitochondria (Figure 16A).  
However, this process was significantly enhanced by alkalinization.  These results, though 
preliminary, suggest that that during apoptosis, intracellular alkalinization is an important 
physiological event that alters the mitochondrial membrane and facilitates the movement of 
BAX. Whether this occurs by enabling the release of the self-associated α9 helix from the 
hydrophobic groove remains to be determined. 
 
 
 
 
 
 
 
Figure 15: EGFP-BAX-CT preferentially associates with alkalinized mitochondria.   
BAX-/- HCT116 cells were equilibrated to pH 7.2 or pH 7.8 by treatment with nigericin for 30 min and 
mitochondria harvested. Another set of BAX+/+ HCT116 cells were transfected with EGFP-BAX-CT and, after 48 
hours, cells were lysed and the cytosol harvested by high speed centrifugation. The EGFP-BAX-CT containing 
cytosol was incubated with neutral or alkaline mitochondria in a test tube for 20 min and than the mitochondria were 
washed several times with 1 M NaCl to remove peripherally associated proteins. Mitochondrial protein content was 
analyzed by SDS-PAGE and immunoblotted with an anti-EGFP antibody and an anti-Prohibitin antibody as a 
mitochondrial loading control. 
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 Figure 16:  EGFP-BAX-CT displays different staining pattern in the presence than in the 
absence of endogenous BAX upon alkalinization. 
BAX+/+ and BAX-/- HCT116 cells were transfected with EGFP-BAX-CT and, after 48 hours, equilibrated to 
pH 7.2 or pH 7.8 by treatments with nigericin for 30 min. Cells were assessed for EGFP expression (green) by 
confocal microscopy.  Mitochondria were identified by staining with anti-HSP60 antibody followed by a rhodamine-
labeled (red) secondary antibody. A diffuse distribution of EGFP-BAX-CT was observed at pH 7.2, with increased 
aggregation EGFP-BAX-CT at pH 7.8 which substantially overlaid with mitochondria suggestion mitochondrial 
membrane binding. More EGFP-BAX-CT associated with alkalinized mitochondria in BAX+/+ cells than BAX-/- 
cells.  
 
2.4 Discussion 
 
In response to an apoptotic signal, BAX translocates from the cytosol to the 
mitochondria. This translocation is thought to be connected with significant conformational 
changes and dimerization (Antonsson et al. 2000;Antonsson et al. 2001;Suzuki et al. 2000), but 
the mechanism is still poorly understood.  
The C-terminal α9 helix of BAX is in literature mostly designated as putative 
transmembrane domain that anchors the protein in membranes (Annis et al. 2005;Antonsson et 
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al. 2000;Antonsson et al. 2001;del Mar et al. 2001) .  In the absence of C-terminal α9 helix, 
BAX does not translocate to mitochondria (Annis et al. 2005;Antonsson et al. 2000;Antonsson et 
al. 2001). The α9 helix of cytosolic BAX is buried in the hydrophobic pocket as demonstrated by 
NMR (Suzuki et al. 2000). My computational mutations of the residues within α9 helix 
demonstrated that lysine 189/190 is an important residue that mediates the binding of the α9 
helix with the hydrophobic pocket. Computational results confirmed the findings from 
mutagenesis and mitochondria translocation experiments, showing that the presence of two 
positive charges at the distal end of C-terminus is necessary for the appropriate subcellular 
distribution of BAX and its translocation to mitochondria during apoptosis. Additional 
computational docking results suggested that the C-terminal α9 helix of BAX is not necessarily a 
putative transmembrane domain as others have suggested.  Computational docking predicted that 
the α9 helix would associate in a reversed direction within the hydrophobic pocket of adjacent 
BAX molecules that resulted in a more energetically favorable interaction. This is in comparison 
with the less energetically favorable forward orientation that occurs during self-association of the 
α9 helix within the hydrophobic pocket. The activation and predicted dimerization of BAX 
would thus be dependent on the occupancy of the hydrophobic pocket by the α9 helix and not by 
the BH3 domain as the prevailing dogma states. In support of this assumption, peptide mimics of 
the α9 helix caused the translocation of wild type BAX and, importantly, the translocation of C-
terminally truncated BAX – BAX deficient of its putative transmembrane C-terminal domain. 
The same effect was not observed by adding the free BH3-only BIM peptide. The peptide-
induced mitochondrial translocation of BAX C-terminal mutant was inhibited by the mutation of 
Glu69/Asn73, conserved residues in the hydrophobic pocket that are in binding proximity of 
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Lys189 when the α9 helix was bound in the reverse orientation. Mutations of residues in the C-
terminus that abrogated the mitochondrial translocation of BAX further strengthened the 
hypothesis, which states that the C-terminal α9 helix is the crucial regulatory domain in BAX 
that is responsible for the translocation and induction of conformational changes, dimerization 
and/or mitochondrial membrane insertion.  
The model proposed states that the C-terminal α9 helix of BAX is not putative 
transmembrane domain but is rather the mediator of membrane-binding conformational changes 
and dimer formation. In response to apoptotic stimuli, the forward-bound, self-associated α9 
helix is released from the hydrophobic pocket. This enables the binding of the α9 helix from 
neighboring BAX molecules in the energetically more favorable reverse orientation within now 
exposed hydrophobic pocket. This results in the exposure of a novel transmembrane domain and 
the formation of dimers that permeabilize mitochondria and cause the release of the apoptogenic 
factors. The C-terminal α9 helix thus regulates the subcellular localization of BAX.  My findings 
imply that the orientation and the type of peptide bound in the hydrophobic pocket of BAX direct 
the subcellular distribution of the protein, retaining the soluble form of BAX in the cytosol or 
inducing the lethal membrane-bound form. 
The importance of the C-terminal helix in the regulation of BAX’s apoptotic activity has 
parallels in the structural studies performed with the anti-apoptotic proteins, BCL-W and BCL-
XL. Examination of the structure of BCL-W demonstrated that the C-terminal α9 helix of BCL-
W is released during apoptosis by accommodating the BH3 domain of BIM (Denisov et al. 
2003). The occupancy of the hydrophobic pocket is thought to regulate the pro-apoptotic activity 
of BCL-W (Hinds et al. 2003). Similarly, the intracellular distribution of BCL-XL is regulated 
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by the occupancy of the hydrophobic pocket by its C-terminal helix (Jeong et al. 2004). The 
exchange of the C-terminal helices between two adjacent BCL-XL molecules led to the 
formation of dimers and the cytosolic retention of BCL-XL, consequently modulating the anti-
apoptotic activity of this protein. 
The prevailing dogma states that the pro-apoptotic function of BAX is modulated though 
its interaction with BH3 domains of other BCL-2 family members (Borner 2003;Gross et al. 
1999). This dogma was supported by studies which showed that BH3 peptides derived from BID 
or BIM triggered the pore forming abilities of BAX, leading to the permeabilization of lipid 
vesicles (Kuwana et al. 2005). Also, detergent treatment induced BAX-BIM association (Marani 
et al. 2002). Yet oligomeric complexes of BAX with BH3-only proteins have not been described 
(Wei et al. 2000), nor has BAX bound to BH3-only proteins been isolated from the apoptotic 
cells (Zhu et al. 2004). BAX was also able to translocate to the mitochondria of the cells 
deficient in the BH3-only proteins BIM and BAD, demonstrating that the redistribution of BAX 
occurs independently of these BH3-only protein (Ekert et al. 2006).  
My study suggests that the activation of BAX is not necessarily mediated by interactions 
with BH3-only proteins, but rather by occupancy of the hydrophobic pocket with the C-terminal 
α9 helix – a process that can suppress or facilitate the exposure of additional membrane-binding 
domains. This finding resolves the controversy as to which domain(s) of BAX is required for 
membrane integration. The C-terminal with its α9 helix is necessary for BAX to associate with 
the mitochondria, since the deletion of this domain retained BAX in the cytosol. However, in the 
absence of a directly attached α9 helix, but in the presence of free peptide mimics of the α9 
helix, I demonstrated that BAX-ΔCT could associate with mitochondria. Thus BAX could 
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contain other transmembrane domains. These domains may not be exposed unless the 
hydrophobic pocket is occupied by the α9 helix in the more favorable reverse orientation. The 
most likely candidates for the membrane-binding domain exposed by occupancy of the 
hydrophobic pocket are helices α5 and α6, which others have shown can form a hairpin (Garcia-
Saez et al. 2005;Garcia-Saez et al. 2006).  The peptides derived from the sequences of helices α5 
and α6 could induce large-sized pores in artificial lipid vesicles (Garcia-Saez et al. 2006).  A 
study of the topology of BAX demonstrated that helices α5 and α6, as well α9, insert into the 
mitochondrial membrane in a stepwise manner (Annis et al. 2005;Suzuki et al. 2000). The 
question remains how the binding of helix α9 in reverse orientation to the hydrophobic pocket 
promotes the exposure of helices α5 and α6. One could hypothesize that a release of self-
associates helix α9 and docking of adjacent helix α9 induces enough stress to cause the 
deformation of the hydrophobic pocket and exposure of additional membrane spanning domains. 
NMR structure of BAX indicates that α5 is a central helix of soluble BAX, buried deeply within 
the protein (Suzuki et al. 2000). The exposure of this helix would thus require significant 
structural rearrangement. 
The findings presented further suggested that Lys189/190 and conserved residues within 
BH3 domain, Glu69 and Asn73, were critical for the regulation of the subcellular localization of 
BAX. A basic amino acid was required at the position 189/190, at the distal end of helix α9, in 
order for BAX to associate with mitochondrial membranes and induce apoptosis. Attaching last 
25 amino acids of BAX, which encompasses helix α9, to EGFP conferred mitochondrial 
targeting to a cytosolic protein, mimicking the behavior of BAX during apoptosis. Studies of the 
C-terminal domains of other BCL-2 family members demonstrated that a transmembrane domain 
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flanked by basic amino acids could function as a targeting signal for mitochondria (Antonsson et 
al. 2000), if this domain was long enough . I observed that the replacement of Lys189/190 with 
leucines generated very potent mutant that spontaneously interacted with mitochondria and 
induced apoptosis. These results indicated that by increasing the hydrophobicity of the helix α9, 
I could turn the helix α9 into a potent transmembrane domain. However, these findings also 
support the alternative function of helix α9 of BAX, where conserved acidic residue Glu69 plays 
important role. Computational docking suggested that Glu69 and Asn73 at the wedge of the 
hydrophobic pocket could interact with Lys189/190 in the helix α9, creating hydrogen bond 
interactions that anchor the helix α9 within the pocket. Results from our mutagenesis studies 
indicated that replacement with uncharged or acidic residues abolished this interaction, while 
replacement by basic residues sustained it. Likewise, I showed experimentally that replacement 
of Glu69 and Asn73 with basic residue abolished the capacity of free BAX C-terminal peptide to 
induce conformational changes needed for the membrane association of BAX, lacking its helix 
α9. 
My results demonstrated that the C-terminal helix α9 is necessary for the regulation of 
the activity of BAX, not as membrane anchor, but rather by binding in reverse orientation to a 
hydrophobic pocket of adjacent BAX molecule to form membrane-binding dimers. Hence the 
self-association or binding of the helix α9 in the forward orientation is functionally different 
from binding in reverse; the former sequesters BAX in the cytosol while the latter promotes 
membrane binding and dimerization. 
I speculate that the initial exposure of the hydrophobic pocket could occur during the 
transient alkalinization that occurs at the early stage of apoptosis. Khaled et al. previously 
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reported that apoptotic stimuli induced a transient alkalization of the cytosol in the cytokine 
dependent cell lines and caused the translocation of BAX (Khaled et al. 1999). Others have also 
shown that the translocation of BAX to the mitochondrial membrane is associated with cytosolic 
alkalization (Belaud-Rotureau et al. 2000;Kim et al. 2003;Lagadic-Gossmann et al. 2004;Tafani 
et al. 2002).  I observed that HCT116 cells also alkalinized upon staurosporine treatment 
independent of the presence of BAX. By the manipulation of intracellular pH, I demonstrated 
that alkalinization could promote the mitochondrial localization of BAX as well as that of EGFP-
BAX-CT. Maintaining a neutral pH in apoptotic cells prevented the movement of BAX to the 
mitochondria (Khaled et al. 1999).  
Despite the fact that some physiological data support the motion that BAX is pH-
responsive, there is no structural data available that demonstrates that significant conformation 
changes are triggered by an alkaline pH.  An NMR study of BAX did not indicate any 
conformational changes between pH 6-8 (Suzuki et al. 2000).  However, epitope-specific 
antibodies, which recognize buried epitopes only in the apoptotic cells, did recognize these same 
epitopes in cells with an alkaline cytosol (Cartron et al. 2004;Khaled et al. 1999). Alkaline 
conditions also caused increased sensitivity of BAX to protease digestion, suggesting that pH 
induces a more relaxed conformation and exposes hidden epitopes (Khaled et al. 1999). The 
important difference between later experiments and the NMR study is that the NMR information 
was acquired in the absence of lipids. Other results were derived in the presence of both BAX 
and mitochondria or lipid vesicles. This is an important piece of information because it is well 
documented that BAX undergoes conformational changes in the presence of lipids (Annis et al. 
2005;Antonsson et al. 2000;Yethon et al. 2003). In support, I was able to demonstrate that the 
affinity of mitochondria for BAX changes upon alkalinization. Alkalinized mitochondria were 
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able to bind BAX as well EGFP-BAX-CT from the cytosol of non-apoptotic cells in a manner 
similar to that observed with apoptotic mitochondria.  Intracellular pH, through its effects upon 
mitochondria, can be an important mediator of the conformational changes of BAX in the 
presence of lipids.  
The influence of an alkaline pH on the mitochondrial membrane physiology remains 
speculative.  A piece of supplementary data not shown was that the affinity of a free C-terminal 
BAX peptide to lipid vesicles increased with an alkaline pH, suggesting that lipids could be the 
pH sensitive component (Tschammer et al. 2007b).  pH gradients across a lipid bilayer can affect 
the diffusion and distribution of individual lipids, sequester some lipids, and induce increased 
lipid bilayer assimetry (Hope, Cullis 1987). Increasing evidence exists that BAX can induce the 
rate of lipid diffusion across a bilayer and move the cardiolipin from the inner to the outer 
mitochondrial membrane (Epand et al. 2003). Recently, BAX was also found to mediate the 
fusion and fission of mitochondria (Karbowski et al. 2006;Karbowski et al. 2002). 
My experiments demonstrated that the C-terminal α9 helix is necessary for the pro-
apoptotic function of BAX, not as a membrane anchor, but as the domain which interacts with 
the hydrophobic groove of adjacent BAX molecules.  This interaction can occur in two different 
orientations: (1) binding in the reverse directional orientation within the hydrophobic pocket of 
adjacent molecules, and (2) binding in the forward that occurs during self-association.  The 
forward orientation inhibits the pro-apoptotic function of BAX by sequestering the protein in the 
cytosol, while the reverse orientation initiates conformational changes, mitochondrial membrane 
integration and subsequent apoptosis. This process seems to be enhanced by transient 
alkalinization of the cytosol, which increases the affinity of the mitochondrial membrane for 
BAX.      
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3 HELICAL INTERACTION ENERGY DISTRIBUTION IN 
TRANSITIONAL PROTEINS 
3.1 Introduction 
 
New developments in biotechnology resulted in an information explosion derived from 
numerous eukaryotic sequencing projects and the subsequent gains in post-genomic research, 
including novel structural studies and new discoveries in protein–protein interactions.  One tool 
that plays an important role in predicting structural and functional properties of the increasing 
number of newly identified and characterized proteins is molecular modeling (Schlick 2006).  
Because modeling predictions are based on existing data, they must be refined whenever new 
and more detailed structures or relationships are available. Homology modeling (Rodriguez et al. 
1998), threading techniques (Lu et al. 2003;McGuffin, Jones 2003), hidden Markov models 
(HMMs) (Eddy 1996;Karplus et al. 1998) and secondary structure prediction using neural 
networks (Lin et al. 2005) are only few examples of the structure-function predictions. A 
drawback with these systems is that most models consider proteins as static objects, despite the 
obvious fact that many proteins (e.g. signaling proteins) are highly dynamic and undergo 
significant conformational changes upon execution of their function.  The structural dynamics of 
proteins can be thus depicted as a continuum with proteins characterized by very rigid structures 
at one end and highly dynamic proteins at the other end.  The dynamic nature of proteins 
structure is important for many biological processes ranging from signaling events to enzymatic 
activity. Changes in the protein structure can occur locally, for example within the active site, 
where minute changes in the side chain position become complementary to the transition state 
(Keough et al. 2005), or globally, where unstructured proteins adopt a well-defined three 
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dimensional (3D) structure upon the formation of a protein complex (Demarest et al. 2002). 
Although critically necessary to elucidate protein function, a method for probing the ability of 
the protein to undergo transitions is not currently available.  
The motivation for undergoing a computational examination of protein transitioning 
originated in my studies on the pro-apoptotic protein BAX (Chapter 2), which is known to 
undergo significant structural transitions in response to apoptotic stimuli. Analyzing the 
interaction energy forces at the interface of the helices within the all α-helical bundle of BAX, I 
sought to develop a measurable parameter that would describe the ability of such proteins to 
undergo transitions.  
Using the 3D structure of BAX, I initially studied the helix interaction energies of the 
carboxyl-terminal region of BAX (known as the α9 helix) in an attempt to understand the role of 
this C-terminal region in the regulation of subcellular distribution of BAX and its apoptotic 
activity. We determined that the interaction of the α9 helix with an internal hydrophobic pocket 
could explain how BAX transitions from a soluble cytosolic protein to a membrane associated 
protein that appears to undergo dimerization as described in the findings presented in Chapter 2 
(Tschammer et al. 2007b).  However, the initiating events that enable interactions between the α9 
helix and the hydrophobic pocket of BAX remained indefinable. In an attempt to elucidate the 
initiating events, we measured the helical interaction energies of all helices within the BAX to 
better understand the static packing arrangement of the helices across the entire 3D structure. 
Our results indicated that BAX displays significant variation in helical interaction energies (IEs) 
that may explain its ability to undergo structural transitions during apoptotic signaling events.  
To test the hypothesis that a significant variation in helical interaction energies correlates 
with biological function, we randomly selected coordinate sets for proteins from the Protein Data 
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Bank (PDB) that were structurally similar to BAX to serve as controls in our calculations. These 
proteins were meant to weigh the level of variation of helical interaction energies within protein 
structures in the all alpha class. Our results demonstrated that a significant number of proteins 
involved in DNA binding, viral invasion, transcription regulation, and other cellular signaling 
events also have a significant variation in helical packing energies, while those proteins that are 
known not to be transitional do not share this property. These results indicate that a measure of 
propensity for transition may be afforded by analysis of the static structures based on the 
statistical distribution of helical interaction energies within a well defined 3D structure. 
 
3.2 Material and Methods 
3.2.1 Structures 
 
The 3D structures of proteins were obtained from the RCSB Protein Data Bank 
(http://www.rcsb.org/pdb).  The ensemble of coordinates representing the NMR structure of 
BAX (PDB ID: 1F16) (Suzuki et al. 2000) was grouped into a conformationally related 
subfamily using the NMRClust program (Kelley et al. 1996b).  The most populated group was 
used for one set of calculations (based on the statistics of the program) and a statistically distinct 
group was used for another set of similar calculations.  Based on the statistical deviation of helix 
packing energies between these groups, our control proteins were primarily chosen from 
structures determined by x-ray crystallography. When NMR structures were used, the most 
populated group (as determined by the NMRClust program) was used for the analysis.  The 
selection criteria for our randomly chose set were as follows: a) under 300 amino acids in length, 
b) belonging to the all alpha class, c) containing similar number of helices (ranging from 3-16), 
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d) no co-factors such as ions or disulfides that might stabilize the proteins´s 3D fold, e) contained 
a single peptide chain, and f) determined by x-ray crystallography. These selection criteria were 
input into the PBD´s database search engine and resulted in 153 proteins that contained regions 
of beta-strands, disulfides, and stabilizing co-factors. Additionally, some coordinate sets were 
missing regions of the structure that prohibited their analysis. These were rejected from our test 
set and the resulting number of structures available for analysis was found to be 74. Our results 
as based on 53 (72%) of these available structures. 
The graphic images were produced by PyMol v0.99 (DeLano Scientific, California).   
 
3.2.2 Energy Calculations 
 
In determining the level of calculations to perform a number of factors was considered. 
Although QM/MM methods have become popular due to their accuracy they are computationally 
expensive and are primarily used for active site analysis and reaction profiling (Cheng et al. 
2005). Methods capable of simulating proteins side-chain flexibility using Monte Carlo 
minimization are also available (Meiler, Baker 2006) and molecular dynamics simulations have 
been shown to be reliable in evaluating protein-peptide interaction energies in dynamic systems 
(Bartels et al. 2005). However, this study deals with the direct measurements of static structures, 
achieving results on 53 independent coordinate sets that had an average of 8 helices each, which 
required calculations for the helix alone, the helix in complex with the protein, and the protein in 
the absence of the helix. Based on this criteria, the use of molecular mechanics (MM3) force files 
with directional hydrogen bonding potentials was chosen to evaluate the static interaction energy 
(Lii, Allinger 1998b). These values are presented as relative interaction energies due to the 
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understanding that calculations completed with different force files potential will result in 
different energy values. Calculations were performed in vacuo, disregarding an explicit 
water/membrane environment, which would result in substantially lower energy values due to 
entropic factors. Only the forces at the interface of each helix were considered in the 
calculations. 
The calculations were performed using the BioMed Cache 6.1.10 program (Fujitsu 
America, Inc., Sunnyvale, CA) as the graphical user interface. MM3 force field calculations were 
performed using parameters as described in the literature. Separate energy calculations were 
performed for: (1) the entire protein (no helices removed), (2) the entire protein, but the 
investigated helix removed, and (3) the helix only. The energy of each molecule was calculated 
until convergence (energy minimization) was reached. Energy terms included Van der Waals, 
electrostatics and hydrogen bonding interactions. All atoms in the structure were locked, except 
protons were allowed to move during the calculations. This was done to ensure that no changes 
in the atomic positions (other than protons) or bond characteristics would occur during the 
calculations relative to the original coordinates in PDB file. A conjugated gradient was used to 
locate the energy minimum. Van der Waals interactions between atoms separated by more than 
9.0 Å were excluded. The interaction energy (IE) was estimated through separate determinations 
of the energy of the complex (Ecomplex), complex without the investigated helix (Ecomplex w/o helix-n) 
and helix alone (Ehelix-n), and by taking the difference between these terms (IE=Ecomplex-(Ecomplex 
w/o helix-n +Ehelix-n)). This difference in the relative energies terms provides the interaction energy 
(IEhelix-n) at the interface of each helix being investigated with respect to the entire structure using 
the MM3 potential. 
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3.2.3 Protons and Ionization States 
 
Because the proton positions are not available in structures determined by x-ray 
crystallography, I edited each structure individually to ensure the proper location of hydrogen 
atoms. This required adjustment in ionization states for individual amino acids in each protein. 
The following guidelines were used for the setting of the ionizations states of the individual 
amino acids: (1) cysteines were protonated, (2) glutamate and aspartate side chains had the 
oxygen farthest from the backbone of the helix investigated assigned a formal negative (-1) 
charge, (3) lysine side chains had a formal positive (+1) charge on the terminal amine, (4) 
arginine side chains were assigned a positive (+1) charge on the nitrogen farthest from the 
backbone of the helix investigated, (5) the new N-termini (generated upon removal of the helix 
of the protein) for the both the protein (without the helix) and the helix itself was given a formal 
positive (+1) charge, and (6) the new C-termini was changed to an aldehyde functional group (no 
charge). For structures determined by NMR, the experimentally determined proton positions 
were used for energy minimization.   
 
3.2.4 Statistical Analysis 
 
The IEhelix-n values for each helix were tabulated as shown in Table 7. The average (AVE) 
helical interaction energy values are shown and provide a measure of the overall stability of the 
helices within the protein structure. The standard deviation (SD) values are calculated to measure 
the statistical variation of all helices within the entire 3D structure. Because different molecular 
mechanics potential functions yield variable interactions energies based on the force fields 
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employed, I propose that the absolute value of the variation over the average (|SD/AVE|) 
provides a general statistical representation of the distribution of helical interaction energies that 
should be independent of the force field potential used for the calculations. Based on the 
distribution of |SD/AVE| values observed, it is apparent that proteins that are known to undergo 
transitions based on experimental evidence have larger |SD/AVE| value compared to those that 
do not undergo transitions. Although no formal cut-off value can be assigned based on the 
proteins used in this study, it is clear that the |SD/AVE| values can serve as a measure of the 
propensity for transition, which is similar to the Random Coil Index (RCI) (Berjanskii, Wishart 
2005) and probabilistic scores (based on pair-wise energy profiles) (Dosztanyi et al. 2005) used 
to assign random coil regions and intrinsically unstructured proteins. 
 
3.3. Results and Discussion 
3.3.1. Variation of helical IE values within each structure 
 
 
In an attempt to understand the transitional mechanism of BAX, I hypothesized that the 
propensity for transition has to be evident from the packing of the helices in 3D structure. The 
calculation of the interaction energy values at the interface (IE) for all the helices in the protein 
showed that the IE values were widely dispersed. Lacking a basis for comparison, I could not 
estimate whether this was common for most proteins or specific for BAX.  In order to make an 
impartial evaluation, I randomly selected the proteins that were in the same structure class and 
had similar molecular properties. This randomly selected set provides values for 72% of the 
available proteins within the PDB that were comparable to BAX. After the analysis of IE values 
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and ranking of the proteins by |SD/AVE| values, the correlation between the dispersion of IE 
values and the property of the protein to undergo transition emerged.  Proteins that undergo 
structural transitions have more dispersed IE values compared to the proteins which do not 
undergo structural transitions (Table 8, Figure 17).  
The interaction energy values for all of the helices of protein phosphatase 5 (1A17) (Das 
et al. 1998), phospholipase-C (1AH7)(Hough et al. 1989), and retinoblastoma tumor suppressor 
(1AD6) (Kim, Cho 1997) were negative, representing favorable interaction energies. The 
average and standard deviation of the interaction energies established that the stability is evenly 
distributed across the entire structure. The ratio |SD/AVE| for all three of these proteins was 
found to be 0.65, 0.73, and 0.94 for protein phosphatase 5, phospholipase-C and retinoblastoma 
tumor suppressor, respectively (Table 9).   In contrast, the IE values of BAX (1F16) (Tschammer 
et al. 2007a) are not evenly distributed across the 3D structure. The core helix of BAX helix 5 
had an IE of -405,14 kcal/mol. The average IE value was -40.57 kcal/mol, indicating a favorable 
overall stability, but the ratio |SD/AVE| was 3.90, indicative of widely dispersed IE. These 
values demonstrated an uneven distribution of helical interaction forces within the stable 3D 
structure of BAX, which may elucidate its ability to undergo structural transitions related to its 
apoptotic activity.  
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Figure 17: Non-transitional proteins have less variability in helical stability. 
Ribbon diagrams of non-transitional proteins and BAX as the representative of transitional proteins. The 
color codes correspond to: blue – the most stable, green – stable, yellow – less stable, orange – unstable, red – very 
unstable. As shown in the figure, the topology of the helices within the structures is similar, but the distribution 
energies are not.  Notably BAX has more unstable helices the structure compared to phospholipase C, PF27 and 
FIS1. 
 
 
No correlation appeared to exist between the helix length (and the corresponding number 
of amino acids capable of interactions) and the interaction energy values (Table 9).  As shown in 
Equation IE=Ecomplex-(Ecomplex w/o helix-n +Ehelix-n), the numbers of atoms are the same (or corrected 
for) in comparing the bound helix compared to the helix alone and the protein without the helix 
present.  My interpretation of these results is that the IE values represent a relative measure of 
the static interaction forces based on: a) the type of interactions (van der Waals, electrostatics, 
and hydrogen bonding) and b) the number of interactions that each helix is capable of making 
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within the protein structure. This indicates that the forces involved in stabilizing a 3D structure, 
or permitting a structural transition, are inherent to the forces involved at the interface and cannot 
be understood based on visual inspection of such properties as helix length and/or the number of 
helices within the structure.  
 
Table 8: Statistical data on helix stabilities.  
The entire set of randomly selected proteins (including BAX) used in this study sorted by |SD/AVE| in 
descending order.   At the top of the list are proteins involved in apoptosis, cellular signaling, DNA binding and 
cellular toxicity which are known to undergo 3D structural transitions and at the bottom of the table are enzymes and 
other proteins that are not involved in such transitions.  The BAX protein (model 20) shows the highest |SD/AVE| 
ratio and represents the statistical variation of helical interactions within the deposited NMR ensemble, while BAX 
(model 1) was from the most populated cluster of the ensemble (see METHODS). Proteins that are involved in 
membrane interactions are shown in italic and show moderate |SD/AVE| values that may reflect their mechanism of 
transition being controlled through significant hydrophobic contact during their structural transitions.   
 
Protein Name PDB 
ID 
Physiological Role AVE Helix 
Energy 
(kcal/mol) 
SD Helix 
Energy 
(kcal/mol) 
⎜SD/AVE⎜ 
BAX (NMR), model 20 1F16 Pro-apoptotic protein -11.90 142.46 11.97 
APAF-1 CARD 1C15 Apoptotic protease 10.98 102.81 9.44 
Colicin E7 immunity 
protein 
1CEI Antibacterial protein 23.22 117.81 5.07 
BAX (NMR), model 1 1F16 Pro-apoptotic protein -40.57 158.09 3.90 
DNA-binding domain of 
TRP repressor 
3WRP DNA binding protein 16.94 64.58 3.81 
APAF-1 CARD domain 2YGS Apoptotic protease -28.23 74.90 2.65 
Methyl-accepting 
chemotaxis protein II 
1JMW Signaling protein -39.55 102.22 2.58 
RGS-like domain from 
PDZ-RhoGEF
1HTJ Signaling protein -51.29 127.58 2.49 
RAD51 1B22 DNA binding protein 42.59 93.64 2.20 
Engrailed homeodomain 1ENH DNA binding protein -75.30 161.05 2.14 
Diphtheria toxin 1DDT Toxin -84.65 166.43 1.97 
Actin-crosslinking 
domain 
1AOA Actin binding protein -166.30 303.62 1.83 
Phosphorelay signaling 
protein YPD1P 
1C03 Signaling protein -176.01 300.13 1.71 
FAT domain of focal 
adhesion kinase 
1K40 Transferase -72.72 106.52 1.46 
Tetracyclin repressor 1BJZ Transcription regulation -182.71 250.54 1.37 
STAT-4 N-domain 1BGF Transcription factor -131.19 178.34 1.36 
B562RIL, a redesigned 
four helix bundle 
1M6T Electron transfer -124.17 163.59 1.32 
Amphiphysin BAR 
domain 
1URU Endocytosis -285.88 357.75 1.25 
SMAC/DIABLO 1FEW Apoptotic protein 213.09 262.03 1.23 
YGFB 1IZM Unknown function 414.86 491.59 1.18 
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 Protein Name PDB 
ID 
Physiological Role AVE Helix 
Energy 
(kcal/mol) 
SD Helix 
Energy 
(kcal/mol) 
⎜SD/AVE⎜ 
KAIA homolog 1V2Z Circadian clock protein -110.49 129.89 1.19 
Apolipoprotein 1AEP Lipoprotein -43.50 48.11 1.11 
Pore-formin domain of 
Colicin A 
1COL Antibacterial protein -126.01 139.42 1.11 
EPHB2 1F0M Signaling protein -91.86 97.07 1.06 
Cyochrome C6 1CTJ Electron transfer 109.89 112.02 1.02 
RGS9 RGS domain 1FQI Signaling protein -176.33 174.23 0.99 
Retinoblastma tumor 
suppressor 
1AD6 Transcription regulation -99.60 94.10 0.94 
Myoglobin 1DWR Oxygen transport -150.58 139.98 0.93 
Phosphate uptake 
regulator 
1XWM Unknown function 255.99 235.99 0.92 
P115RhoGEF domain 1IAP Signaling protein -99.49 89.93 0.90 
Histon HMFB from M. 
fervidus 
1B6W DNA binding protein 
 
-128.78 114.10 0.89 
Bovine cyclin A3 1VIN Binding protein -118.63 102.56 0.86 
Ribosomal protein S15 1A32 Ribosomal protein -227.578 191.697 0.84 
Glutathione S-transferase 13GS Catalysis of the conjugation 
of reduced glutathione  
-213.85 178.00 0.83 
Calponin homology 
domain from beta-spectrin 
1BKR Acting binding -90.43 75.14 0.83 
CALM-N N-terminal 
domain of clathrin 
1HF8 Clathrin -179.169 148.504 0.83 
Endonuclease V 2END Endonuclease -266.10 210.00 0.79 
Epsin N-terminal 
homology domain 
1EYH Cell lycle 130.13 100.41 0.77 
Middle domain of 
EIF4GII 
1HU3 Translation -129.78 98.94 0.76 
Phospholipase C 1AH7 Hydrolysis of 
phosphatidylcholine 
-329.98 241.89 0.73 
Interferon beta 1WU3 Cytokine -124.56 123.89 0.71 
Apolipoprotein E4 1GS9 Lipoprotein -200.75 143.94 0.72 
N-terminal fragment of 
NS1 protein 
1AIL RNA binding protein -175.46 123.89 0.71 
Hyperplastic disc protein 1I2T Ligase -133.62 90.02 0.67 
Plasmodium falciparum 
gamete gene PF27 
1N81 Unknown function -228.95 148.64 0.65 
Serine/threonine protein 
phosphatase 5 
1A17 Skeletal muscle calcium 
binding protein 
-227.24 147.27 0.65 
BH domain from Graf 1F7C Signaling protein -101.77 64.31 0.63 
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 Protein Name PDB 
ID 
Physiological Role AVE Helix 
Energy 
(kcal/mol) 
SD Helix 
Energy 
(kcal/mol) 
⎜SD/AVE⎜ 
Human mitochondrial 
fission protein Fis-1 
1NZN Mitochondrial fission -82.50 49.90 0.60 
CRO protein 2CRO Gene regulation -132.33 71.99 0.54 
Troponin 1A2X Calcium-dependent regulator 
of muscle contraction 
753.19 382.73 0.51 
EPH receptor 1B0X Transferase -63.62 26.83 0.42 
Sperm lysin 2LIS Cell adhesion -152.24 49.88 0.33 
 
Table 9: Helical stability of three non-transitional proteins 
Legend: AVE – average, SD – standard deviation 
 
Helix 
Number 
PP-5 (1A17)) Phospholipase C (1AH7) Retinoblastoma 
tumor 
suppressor 
(1AD6) 
Sequence Helix Energy 
(kcal/mol) 
Sequence Helix Energy 
(kcal/mol) 
Sequence 
 
Helix Energy 
(kcal/mol) 
1 22-40 -44.34 14-27 -147.49 384-390 -53.46 
2 44-57 -71.50 35-52 -308.70 398-405 -59.11 
3 62-74 -234.89 86-103 -221.21 412-434 -227.56 
4 78-91 -149.35 106-122 -862.70 439-468 -281.28 
5 96-108 -432.87 126-130 -254.66 474-477 -66.62 
6 112-125 -369.85 141-148 -209.35 480-497 -83.43 
7 130-164 -287.92 173-186 -463.81 516-520 -57.20 
8   193-204 -41.08 525-538 -88.23 
9   206-242 -460.79 544-559 20.46 
       
AVE  -227.24  -329.98  -99.60 
SD  147.27  241.89  94.10 
⎜SD/AVE⎜  0.65  0.73  0.94 
 
The distribution of IE values for the helices with the respect to the 3D structures of 
phospholipase-C, PF27 (Sharma et al. 2003), FIS1 (Karbowski et al. 2002), and BAX are 
graphically depicted in Figure 17. These structures demonstrate that IE of the helices varies 
independently of the topological arrangement within the 3D structure. This is a further indication 
that the number and types of interactions each helix is capable of making is the most important 
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factor in understanding the variation in IE.  The green and blue colors represent regions of high 
stability (negative IE) and regions of orange and red colors represent regions of relative 
instability (positive IE).  The C-terminal helix in BAX (α9, shown in light green) had a favorable 
IE (-76.71 kcal/mol) and is located next to two helices (#3 and #4) that are relatively unstable. 
Helix α9 seems to be critical for membrane localization though its interactions with the 
hydrophobic pocket (Tschammer et al. 2007b) and most likely plays a role in stabilizing or 
destabilizing other helices, enabling a structural transition to occur that facilitates mitochondrial 
membrane insertion or association with another BCL-2 related protein.  
The complete set of randomly selected proteins (including BAX) used in this study is 
provided in Table 8.  The BAX protein (model 20) is at the top of the list with a |SD/AVE| ratio 
of 11.97.  This ratio was the highest in our study and appears to represent the statistical variation 
of helical interactions within the deposited NMR ensemble for the BAX protein. BAX (model 1) 
was from the most populated cluster of the ensemble (see Methods) and this structure had a value 
of 3.91. The value 11.97 was obtained with one set of coordinates that was part of the deposited 
ensemble, but did not cluster with model 1. For this reason, I used NMR structures sparingly in 
the study and when they were used, only the most populated cluster from the ensemble was used 
for IE calculations.   
As shown in Table 8, the variation in IE values for proteins varies significantly even 
though these proteins are in the all alpha-class and have similar molecular properties. This 
distribution provided a basis for comparing the helical IE values within BAX, as well as other 
proteins in the all alpha-class. Because BAX is known to undergo a structural transition, and is 
near the top of the list, I interpret these results as a mean of measuring the propensity for the 
transition for proteins with stable 3D structures. However, as described later in the report, the 
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|SD/AVE| values may differ depending on the mechanism of transition and the involvement of 
other proteins, or membranes, which are involved in initiating the transition for each protein. 
 
3.3.2. Statistical variation within the randomly selected set 
 
Following the analysis of BAX and comparing the IE values of this protein to those that 
were randomly selected, I came to the understanding that the statistical variation in IE values 
may represent a measure of propensity for transition within proteins that have a defined 3D fold. 
When considering a protein that has a biological role in signaling, and undergoes a structural 
transition, the forces required to induce this transition (which may be afforded though binding 
another biological molecule or a membrane surface) must be stronger than those forces 
stabilizing the structure prior the transition. For this reason, I suggest that the statistical variation 
of IE represents regions within 3D structures that make these processes energetically favorable 
and yet allow a global stability within protein structure that enables the molecule to remain in a 
native state prior to transition. 
The average value, standard deviation and absolute ratio |SD/AVE| for all the randomly 
selected proteins (Table 8) showed trends that appear to correlate with each protein´s 
physiological role. While BAX is near the top of the list, APAF-1 CARD (Caspase Recruitment 
Domain) protein also shows a high |SD/AVE| ratio. This protein consists of six tightly packed 
amphipatic alpha-helices. Its cellular role involves the activation of Caspase-9 though the 
homophilic CARD/CARD interaction. The |SD/AVE| ratio for this protein is 9.44. The structure 
of the protein has been determined in the unbound state (Zhou et al. 1999) and in complex with 
pro-domain of pro-caspase 9 (Qin et al. 1999) and shows a significant structural mobility upon 
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binding.  Almost all the helices within the protein undergo some level of structural 
rearrangement upon ligand binding as demonstrated by the Cα trace (Figure 18). The protein 
undergoes the smallest conformational rearrangement in the segment of the helix α5 (amino 
acids 50-64). This segment had an IE of -190 kcal/mol and was the most stable helix in the 
structure. The segments represented by helix α3 (amino acids 23-31) and helix α4 (amino acids 
37-46) had the most unfavorable IE (97.45 and 115.24 kcal/mol, respectively) and showed the 
most rearrangement upon ligand binding. These two helices are in direct contact with the CARD 
domain of procaspase-9, which may indicate that regions of relatively unfavorable IE find 
stability in binding their particular biological targets.   
In addition to the analysis of the NMR structure of the APAF-1 CARD domain, a second 
structure of APAF-1 CARD domain obtained by X-ray crystallography was analyzed. The 
|SD/AVE| ratio for this from was 2.65. Although this ratio was considerably smaller that that of 
the NMR structure (9.44), it positioned this protein among the proteins that undergo structural 
transitions. Additionally, the helical segments of the two proteins (as given in the PBD header) 
are slightly different. The most stable segments (amino acids 50-64 (NMR) and 48-61 (X-ray) 
were consistent in both structures and the regions described above (that interact with the CARD 
domain of procaspase-9) appeared to be less stable due to higher IE. These results suggested that 
the IE values are not dependent on the method used for structure determination, the resolution, or 
the helical limits, because the most stable segments were similar in both structures.  
The TRP repressor (3WRP) has a |SD/AVE| ratio of 3.81. The structure of this protein 
was determined by x-ray crystallography with a resolution of 1.8 Å (Orth et al. 1999). The 
authors of this study found different forms of the proteins fro different crystallization conditions 
and described this flexibility based on the TRP repressor´s ability to search for and adhere to its 
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different operator sites (Orth et al. 1999). Therefore, this protein has an intrinsic flexibility that 
had been well characterized and the |SD/AVE|  ratio correlates well with these observations. The 
TRP repressor undergoes rearrangement upon DNA binding, which can be observed in the Cα 
trace of the bound (green) and unbound forms (red).The most stable region of this protein is 
found to be the region around 79-91 (helix 5) with an IE value of -90,48 kcal/mol. This helix is 
one of the helices that make direct contact with the DNA. The regions from 46-63 (helix 3) and 
68-74 (helix 4) have IE of 61.24 and 88.27 kcal/mol, respectively, and are the least stable helices 
within the structure. These two helices are on the outside of the structure and may find stability 
by interacting with helix 5 (Figure 18). These two helices (along with helix 5) are found at the 
interface of the bound DNA with helix 5 bound in the major groove (Figure 18). This helix also 
overlays best in the Cα trace between the bound and unbound form, which may be interpreted as 
a further measure of the stability of this helix. Unlike the APAF-1 CARD protein, the TRP 
repressor uses regions of relative stable and unstable regions for DNA binding, but the regions 
with higher IE appear to be involved in both cases. 
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Figure 18: Structural changes for transitional proteins based on Cα overlays. 
The green Cα trace represents the protein in the bound form and red traces represent the unbound form of 
the proteins.  For the Trp-repressor, APAF-1 CARD, and chemotaxis proteins, their respective ligands (DNA, 
caspase-CARD domain, and aspartate) are shown to identify the regions of where interactions occur.    
 
 
The ligand binding domain of the methyl-accepting chemotaxis protein II is also 
represented in the PDB in a bound and unbound form. The unbound form (Figure 18) shown in 
red is slightly different than the protein with bound aspartate (green). Although the changes in 
the helical positions (based on Cα traces) are not as dramatic as those found for the TRP repressor 
and the APAF-1 CARD domain, there are noticeable differences that can be observed in 
comparing the two forms. The region with most favorable IE within this protein are 87-110 (-
140.08 kcal/mol) and 116-144 (-191.91 kcal/mol). These two helices are on the opposite face of 
the aspartate binding region. Amino acids 40-75 (41.89 kcal/mol), 145-152 (22.59 kcal/mol), and 
153-175 (50.15 kcal/mol) which represent helices  #2, 5 and 6 are on the interface where the 
aspartate molecule is bound and have the highest IE values. This protein has a |SD/AVE| ratio of 
2.58, which is lower than the previously described proteins, but higher than most of the proteins 
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from the randomly selected list. This lower |SD/AVE| ratio appears to correlate with the smaller 
changes in the Cα traces compared to the previously described proteins. The APAF-1 CARD 
proteins shows the most dramatic change (Figure 17) and has the highest |SD/AVE| ratio (9.44), 
whereas the TRP repressor (3.81) and chemotaxis protein (2.58) have decreasing values that 
correlate with more fine changes in the bound and unbound forms as seen though the Cα traces. 
As demonstrated by the data above, the larger |SD/AVE| ratio correlates with those 
proteins that are involved in protein-DNA and protein-protein interactions. Additionally, the 
statistical variation in |SD/AVE| ratio as a measure of propensity for transition is supported by 
changes in the structures when comparing the bound and unbound forms. However, as discussed 
below, the degree of statistical variation within a single structure may vary depending on the 
types of forces involved in initiating the transition. 
  
3.3.3. IE distribution and protein function 
 
A clear division of statistical variation within IE values would be a convenient mean of 
predicting propensity of the protein to undergo transition. The comparison of |SD/AVE|  ratio of 
the proteins with the published experimental description of the proteins tendency to undergo 
transition yielded |SD/AVE|  ratio distribution between 1.11 and 9.44, and for the proteins which 
do not undergo transition between  0.33 and 1.06. The approximate cut-off value could be around 
1.1 with transitional proteins having |SD/AVE|  ratio larger than 1.1 and non-transitional proteins 
ratio smaller than 1.1.  
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Proteins with the |SD/AVE|  ratio of 1.1 or above have more unfavorable average IE 
values compared to those having |SD/AVE|   ratio less than 1.1 (Table 8), although no correlation 
to function can be made based on average IE values alone. The non-transitional proteins show a 
slight correlation that provides a slope of -1.08 in the plot of standard deviation vs average IE 
value, while the transitional proteins appear to be more scattered and have varied average IE 
values, as well as higher standard deviations (Figure 19). For this reason, the |SD/AVE|  ratio 
appears to be a better measure if propensity for transition than the average energy values alone. 
As shown in Figure 19, it appears to be a region where the correlation (based on non-transitional 
proteins) is lost. For example, proteins such as actin binding protein (1AOA, -166.30 kcal/mol), 
the phosphorelay signal transduction protein YPD1P (1C03, -176.01 kcal/mol), tetracycline 
repressor (1BJZ, -182.71 kcal/mol), and the BAR membrane curvature sensor protein (1URU, -
285.88 kcal/mol) have all favorable IE, but have |SD/AVE|  ratio above 1.2. This demonstrates a 
wider statistical distribution of helical interaction forces across the entire protein structure in a 
structure that appears to be very stable. Based on their functional classification, these types of 
proteins would be expected to have some flexibility within their 3D structures, but this is not 
apparent based on the average IE values and their stable 3D structures.  
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Figure 19: Graphical representation of the average IE values and standard deviations.  
The proteins that are known not to be involved in 3D structural transitions are shown with black diamonds 
and those known (or described in the literature) to undergo structural rearrangement are shown with green circles.  
While the non-transitional proteins have some correlation between their average IE values and deviations, the 
transitional proteins appear to be more scattered and have no correlation.   
 
 
3.3.4. Proteins with unknown function 
 
Many proteins in the current databases are annotated as “unknown function”, because 
their structures were obtained prior to any biological studies being performed. While 3D 
structures are of values in many areas of research, the lack of biological information makes the 
choice of further characterization of these proteins difficult. Based on the results presented in this 
study, it may be possible to classify these unknown proteins based on their |SD/AVE| ratio to 
determine which proteins may be of interest because of their potential role in signaling and/or 
transition.  
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Three of the proteins in our randomly selected set are annotated as unknown function in 
the PDB. The first protein is a gametocyte protein essential for sexual development in 
Plasmodium falciparum (1N81) known as Pfg27. This proteins has been described as a RNA and 
SH3 domain binding protein capable of binding two SH3 domains simultaneously (Sharma et al. 
2003). It has an average IE value of -228.95 kcal/mol and |SD/AVE|  ratio of 0.65. Based on this 
structure and the described biological roles, this protein does not appear to be involved in 3D 
structural transitions related to its function. 
The second protein of unknown function is annotated as a phosphate uptake regulator 
(1XWM) homologous with PhoU proteins that function as negative uptake regulators in E.coli. 
This protein has an average IE value of 255.99 kcal/mol with a |SD/AVE|  ratio of 0.92. Based 
on these values, we might predict that the deviation within helical energy distribution for this 
protein may indicate a transition in the 3D structure being involved in the mechanism of 
controlling phosphate uptake, but biological data to support this is still pending. It has been 
shown that the PstSCAB transporter and PhoU may be regulated by a mechanism that may 
involve their interactions with each other as well as inorganic phosphate and the sensor proteins, 
PhoR (Steed, Wanner 1993). PhoU might use its lowered helical interaction energy to promote 
interactions with the transporter protein, other proteins in the phosphate uptake pathway, or 
possibly membrane lipids. However, this would require solid experimental evidence to support 
this mechanism, and based on the distribution of |SD/AVE|  ratio in this study, this protein is 
clearly intermediate and one cannot determine the propensity of transition for this protein based 
on these values.  
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The third protein is HI0817 Haemophilus influenzae (1IZM) (Galkin et al. 2004). It has 
an average IE value of 414.86 kcal7mol with a |SD/AVE|  ratio of 1.18. This protein is classified 
as a conserved hypothetical protein and homologous to a 24-member family that includes a brad 
number of human (12), bovine, insect and plant pathogens. Although the biological mechanism 
for this conserved pathogen is not known, I would predict based on these values (and those from 
other proteins in my test) that its biological mechanism is related in some way to the statistical 
distribution of interaction energies across the 3D structure. This would fit in the grouping of 
proteins with relatively high IE values and |SD/AVE|  ratio such as those found for the 1AEP and 
1COL structures that are involved in membrane associated protein transitions. However, 
experimental evidence is needed to support this proposed transition. 
While further studies need to be completed to determine the biological function of 
unknown proteins before they are classified as transitional, I feel the statistical methods outlined 
in this report may provide insight for future studies on those proteins that are conserved across a 
number of species, yet have no clear biological role.  
 
3.4. Conclusions 
 
Biological signaling is often controlled by the binding events that are transient in nature 
involving random coil, molten globules, and proteins with stable 3D folds. While the 
classification and mechanisms of signaling for random coil and molten globule proteins can be 
understood based on their ability to undergo structural transitions, no measure of propensity for 
transition is available for stable proteins that are involved in signaling. With the idea of a 
“continuum of protein structure” being available to describe proteins involved in cellular 
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signaling comes the understanding that these types of transitions (and the mechanism by which 
they occur) should have some measurable parameter, even for proteins with stable 3D folds. For 
intrinsically disordered and random coil proteins, these parameters are found in the pair-wise 
indexing and random coil index, respectively. Although these parameters do not have statistical 
cut-off values that clearly classify proteins as completely random or completely unstructured, 
they do provide an indication of the degree of randomness and/or potential lack of 3D structure. 
Analysis of helical interaction energies, as described in this study, appears to provide a similar 
type of measurable parameter, with the difference being that static energies are used and the 
proteins that are being compared need to be in the same structural class and lack factors that 
stabilize the 3D fold. 
Analysis of stable 3D structures using the method outlined in this study will be valuable 
in guiding experimental efforts to understand the transitional mechanisms of proteins.  With an 
increasing number of proteins being discovered by structural genomics efforts (Stevens et al. 
2001) (without experimental data such as 1IZM and 1XWM), parameters such as those examined 
in this study may provide information about those areas of least stability within a protein’s 3D 
structure and identify the region(s) of contact for the biological molecules that are involved in 
the interaction(s). Although this study only addresses helical interaction energies in small 
proteins of the all alpha-class, it is possible to assume that other types of proteins, of varying 
structural complexity, will also have stability trends within their 3D structures that will assist in 
understanding their ability to control biological signaling events and as well as elucidate the 
mechanisms of transitioning that regulate their function. 
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4 ANALYSIS OF HELICAL INTERACTION ENERGIES TO PROBE 
THE STABILITY AND MECHANISMS OF STRUCTURAL TRANSITIONS IN 
THE BCL-2 PROTEIN FAMILY 
 
4.1 Introduction 
 
Three-dimensional (3D) protein transitions are important for a number of biological 
processes and signaling events ranging from host invasion to DNA binding and apoptosis (Hinds 
et al. 2003;Patel et al. 1990). These structural transitions may occur locally at flexible loop 
regions, or involve complex folding events like e.g. diphtheria toxin (Dumont, Richards 1988). 
Because these structural transitions are governed by the stability of a protein’s localized domains 
and/or secondary structural elements, the analysis of the thermodynamic stability of these 
individual elements should provide insight into the mechanisms of the transitions. Such 
measurements should provide a mean of computational classification of those proteins that have 
a propensity for transition, as well as identify domains within the protein that are likely to be 
involved in the initiation of 3D structural changes. My previous study (Tschammer et al. 2007a) 
showed that this type of the parameter exists. Analysis of the static interaction energy (IE) for the 
helices within all-alpha class proteins indicated that the transitional proteins have wider 
distribution of IE, resulting in higher |SD/AVE| ratio compared to non-transitional proteins. BAX 
appeared to be the protein with one of the broadest IE distribution among the evaluated proteins. 
BAX is a member of BCl-2 family of apoptotic regulators (Borner 2003;Cory et al. 
2003). The BCL-2 family can be divided in two functional categories – those that mediate 
survival, such as BCL-XL and BCL-2, and those that mediate death, such as BAX, BID or BIM 
– based on the presence of one or more BCL-2 homology (BH) domains. Structural studies of 
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BCL-2 family members demonstrated that the members retain a similar folded structure despite 
their significant difference in the amino acid sequence (Petros et al. 2004). NMR or X-ray 
structures are available for six family members (BCL-XL (Muchmore et al. 1996), BCL-2 
(Petros et al. 2001), KSHV-BCL-2 (Huang et al. 2002), BCL-W (Denisov et al. 2003), BAX 
(Suzuki et al. 2000) and BID (Chou et al. 1999;McDonnell et al. 1999). The solution structure of 
BAX showed that BAX is folded in a similar manner than other BCL-2 family members. Helices 
#2, #3, #4 and #5 form a hydrophobic pocket which is occupied by the C-terminal α9 helix 
(Suzuki et al. 2000). BCL-XL structure contains similar pocket which is occupied by the bound 
BH3 peptide mimics (Petros et al. 2004;Petros et al. 2000).  
Based on my previous work in which I analyzed the mechanism of BAX activation 
(Tschammer et al. 2007b) and the variations in the helical stability in static structures of proteins 
(Tschammer et al. 2007a), I focused on the analysis of  3D structures of BCL-2 family members 
deposited in the Protein Data Bank (PBD)(Berman et al. 2000). The reason for studying the 
BCL-2 family proteins originates in their ability to undergo structural transitions during 
execution of their biological function (Borner 2003;Schlesinger et al. 1997;Zhang et al. 2004). 
Little is known how these structural transitions occur. Using methods of computational 
modeling, I analyzed different BCL-2 family members and found that these proteins have, 
similar as BAX, broad distribution of IE, although the force of interaction between various 
helices within each structure varied. This variations in the IE within each structure and the 
changes that occur upon peptide binding led to conclusion that these differences could reflect 
different transitional mechanisms and/or functions for members of the BCL-2 protein family.     
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4.2 Materials and Methods 
4.2.1 Structures 
 
The 3D structures of proteins were from the RCSB Protein Data Bank 
(http://www.rcsb.org/pdb). The representatives of BCL-2 family of proteins are: BAX (PDB ID 
1F16) (Suzuki et al. 2000), BCL-W (1MK3) (Denisov et al. 2003), BCL-2, isoform 1 (1G5M) 
(Petros et al. 2001), BCL-XL X-ray structure (1R2D) (Muchmore et al. 1996), BCL-XL NMR 
structure (1MAZ) (Muchmore et al. 1996), human BID (2BID) (Chou et al. 1999), mouse 
BID(1DDB) (McDonnell et al. 1999) and CED9 (1OHU) (Woo et al. 2003). BHRF1 protein 
from Epstein-Barr Virus (EBV) (1Q59) (Huang et al. 2003) and BCL-2 homolog from Kaposi´s 
sarcoma-associated herpes virus (1K3K) (Huang et al. 2002) are the representatives of viral 
BCL-2 homologs. Coordinates of BCL-XL in complex with the peptides were as follows: BAD 
(1G5J) (Petros et al. 2000), BAK (1BXL) (Sattler et al. 1997) and BIM (1PQ1) (Liu et al. 2003). 
The coordinates for CED) in complex with the EGL-1 peptide were PDB ID code 1TY4 (Yan et 
al. 2004). 
The graphic images were produced by PyMol v0.99 (DeLano Scientific, California).   
 
4.2.2 Energy Calculations 
 
 In determining the level of calculations to perform a number of factors was considered. 
Although QM/MM methods have become popular due to their accuracy they are computationally 
expensive and are primarily used for active site analysis and reaction profiling (Cheng et al. 
2005). Methods capable of simulating proteins side-chain flexibility using Monte Carlo 
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minimization are also available (Meiler, Baker 2006) and molecular dynamics simulations have 
been shown to be reliable in evaluating protein-peptide interaction energies in dynamic systems 
(Bartels et al. 2005). However, this study deals with the direct measurements of static structures, 
achieving results on 53 independent coordinate sets that had an average of 8 helices each, which 
required calculations for the helix alone, the helix in complex with the protein, and the protein in 
the absence of the helix. Based on this criteria, the use of molecular mechanics (MM3) force files 
with directional hydrogen bonding potentials was chosen to evaluate the static interaction energy 
(Lii, Allinger 1998b). These values are presented as relative interaction energies due to the 
understanding that calculations completed with different force files potential will result in 
different energy values. Calculations were performed in vacuo, disregarding an explicit 
water/membrane environment, which would result in substantially lower energy values due to 
entropic factors. Only the forces at the interface of each helix were considered in the 
calculations. 
The calculations were performed using the BioMed Cache 6.1.10 program (Fujitsu 
America, Inc., Sunnyvale, CA) as the graphical user interface. MM3 force field calculations were 
performed using parameters as described in the literature. Separate energy calculations were 
performed for: (1) the entire protein (no helices removed), (2) the entire protein, but the 
investigated helix removed, and (3) the helix only. The energy of each molecule was calculated 
until convergence (energy minimization) was reached. Energy terms included Van der Waals, 
electrostatics and hydrogen bonding interactions. All atoms in the structure were locked, except 
protons were allowed to move during the calculations. This was done to ensure that no changes 
in the atomic positions (other than protons) or bond characteristics would occur during the 
calculations relative to the original coordinates in PDB file. A conjugated gradient was used to 
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locate the energy minimum. Van der Waals interactions between atoms separated by more than 
9.0 Å were excluded. The interaction energy (IE) was estimated through separate determinations 
of the energy of the complex (Ecomplex), complex without the investigated helix (Ecomplex w/o helix-n) 
and helix alone (Ehelix-n), and by taking the difference between these terms (IE=Ecomplex-(Ecomplex 
w/o helix-n +Ehelix-n)). This difference in the relative energies terms provides the interaction energy 
(IEhelix-n) at the interface of each helix being investigated with respect to the entire structure using 
the MM3 potential. 
 
4.2.3 Protons and Ionization States 
 
Because the proton positions are not available in structures determined by x-ray 
crystallography, I edited each structure individually to ensure the proper location of hydrogen 
atoms. This required adjustment in ionization states for individual amino acids in each protein. 
The following guidelines were used for the setting of the ionizations states of the individual 
amino acids: (1) cysteines were protonated, (2) glutamate and aspartate side chains had the 
oxygen farthest from the backbone of the helix investigated assigned a formal negative (-1) 
charge, (3) lysine side chains had a formal positive (+1) charge on the terminal amine, (4) 
arginine side chains were assigned a positive (+1) charge on the nitrogen farthest from the 
backbone of the helix investigated, (5) the new N-termini (generated upon removal of the helix 
of the protein) for the both the protein (without the helix) and the helix itself was given a formal 
positive (+1) charge, and (6) the new C-temini was changed to an aldehyde functional group (no 
charge). For structures determined by NMR, the experimentally determined proton positions 
were used for energy minimization.   
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4.2.4 Statistical Analysis 
 
The IEhelix-n values for each helix were tabulated as shown in Table 8. The average (AVE) 
helical interaction energy values are shown and provide a measure of the overall stability of the 
helices within the protein structure. The standard deviation (SD) values were calculated to 
measure the statistical variation of all helices within the entire 3D structure. The structures were 
ranked in terms of their |SD/AVE| ratio to provide a measure of the propensity for transition as 
described in Chapter 2. As shown in Table 8, significant changes in the |SD/AVE| ratios were 
found when BCL-2 family members are in the complex with various peptides. 
 
4.2.5 Changes in the secondary structure 
 
The CED9 and BCL-XL proteins in this study were analyzed with and without small 
peptides bound. In some cases changes in the secondary structure have occurred upon peptide 
binding. In order to represent the interaction energies accurately, two sets of calculations were 
completed. The first set used the same atoms for bound and free forms, irrespective of any 
change in the secondary structure. The helical boundaries for CED9 and BCL-XL proteins 
(without any bound peptide) were determined by the information in the PDB header. These same 
atoms were then used for calculations for the bound form even if these atoms were no longer in a 
helical conformation. This allowed direct comparison of the energies for the free and bound 
forms using the same number of atoms in each calculation. Any change in the number (or type) 
of atoms used would change the relative interaction energy values, and make the two sets of 
values difficult to compare accurately. This set of values was designated as “Set 1”. In a second 
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set of calculations, the interaction energies for the CED9 and BCL-XL complexes were 
calculated with the helix boundaries taken directly from the PDB header. This allowed 
comparison of any changes in helical interaction energy (IE) relative to the resulting changes in 
the secondary structure. The data comprised “Set 2” in the tables. Specifically, the following 
changes in the two structures occurred upon peptide binding (based on PDB secondary structure 
annotation): (1) BCL-XL residues 103-106 are in a helix in the bound form, but form a beta-turn 
in the free form, and (2) CED9 residues 141-144 form a beta-turn in the absence of the peptide, 
but form a helix in the presence of the peptide.  
 
4.3 Results 
 
My previous analysis of the helical interaction energies (IEs) in the all alpha-class 
proteins that are known to undergo structural transitions demonstrated a broad distribution of IEs 
within the structure (Tschammer et al. 2007a). Within the randomly chosen set of proteins which 
were used in the mentioned study, BAX was estimated to have one of the broadest IE 
distributions of all the proteins analyzed. Based on this observation and the fact that BCL-2 
family proteins employ structural transitions to regulate apoptotic events, I analyzed the IEs for 
those BCL-2 family proteins for which structural information is available in free and bound form 
with the intention to detect the changes in the IE distribution which occur upon ligand binding.  
 
 
 
 89
4.3.1 Helix Stability and Packing of BCL-2 Family Members 
 
The common feature of the known structures of the BCL-2 family members is so-called 
core region of the protein represented by at least one helix. The other helices are arranged around 
this core set and form α-helical bundle (Figure 20).  Despite the overall similarity in the fold of 
BCL-2 family members (Petros et al. 2004), I detected significant differences in the helix 
stability and helical packing among different members (Table 10).  
All of the BCL-2 family proteins analyzed in this study had |SD/AVE|values that were 
greater than 1.1 when the protein was not in the complex with a peptide/ligand (Table 10). The 
|SD/AVE| ratios ranged form 1.17 for BHRF1 (a viral BCL-2 homolog) to as high as 11.97 for 
BAX (Model 20). The BAX structure with the |SD/AVE| ratio of 11.97 was derived from  the 
least clustered coordinate set obtained from the NMR ensemble of structures deposited in the 
PBD (see 4.2 Material and Methods). The most populated cluster resulted in a |SD/AVE| value of 
3.9 (BAX, Model 1). Even with this variability in |SD/AVE| ratio for different members of NMR 
ensemble, BAX showed a significant distribution of IE within its 3D structure. The BCL-XL 
structure (as determined by NMR) had a |SD/AVE| ratio of 4.38 and the structure determine by 
X-ray crystallography 4.24. These results demonstrated that structures determined by NMR 
(using the most populated group of structures within the ensemble) and X-ray crystallography 
have comparable |SD/AVE| ratio and that the IEs are not dependent on the method of the 
structure determination. 
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Figure 20: BCL-2 family proteins have stabile central helix. 
Ribbon diagrams of protein belonging to the BCL-2 family color coded by stability.  The color codes 
correspond to: blue – the most stable, green – stable, yellow – less stable, orange – unstable, red – very unstable. As 
shown in the figure, the topology of the helices within the structures is similar, but the distribution energies are not.  
Notably BAX has more unstable helices on the outer edge of the structure compared to BCL-W, BCL-XL, and BID.  
I interpret these variations as potential differences in the mechanism of transition for each structure, which is 
governed by each protein’s distribution of helical interaction energy values and overall stability.  
 
The differences observed in the helical stability and packing of BCL-2 family proteins 
mirrors their unique pro- or anti-apoptotic function. The BCL-2 family members with multiple 
conserved BH domains, BAX, BCL-W, BCL-XL, BCL-2 and BCL-2 homolog of Kaposi’s 
sarcoma virus, demonstrated distinctive pattern in the helical stability and the helical packing 
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with only one core helix relatively stable (α5, the energy value in the range from -400 in BAX to 
10 kcal/mol in BCL-2; Table 11). CED9 has two relatively stable helices (α5, α6) that form a 
similar stable core (-280 to 380 kcal/mol). The central stable core helix (or helices in CED9) is 
the main component of the hydrophobic groove, which is an essential structural and  functional 
element among anti- and pro-apoptotic BCL-2 family members (Petros et al. 2004).  
 
Table 10: Statistical data on helix stabilities for BCL-2 family proteins.  
Standard deviation (SD), average (AVE), and |SD/AVE| values for the BCL-2 protein family investigated 
in this study.  Values are sorted and ranked by |SD/AVE| value.  Protein Data Bank (PDB) codes for the atomic 
coordinates are also included.  This distribution represents the variation in helical interaction energies for the various 
BCL-2 protein family members and demonstrates their broad distribution of energies that may enable structural 
transitions to occur. 
 
 
Protein Name PDB ID Physiological Role AVE Helix 
Energy 
(kcal/mol) 
SD Helix 
Energy 
(kcal/mol) 
⎜SD/AVE⎜ 
BAX, Model 20 1F16 Apoptosis regulator -11.90 142.46 12.0 
BCL-XL 1MAZ Apoptosis regulator -46.75 204.69 4.4 
BCL-XL 1R2D Apoptosis regulator -61.26 259.98 4.2 
BAX, Model 1 1F16 Apoptosis regulator -40.57 158.09 3.9 
Human BID, Model 15 2BID Apoptosis regulator 66.83 238.63 3.6 
BCL-2 homolog from 
KSHV 
1K3K Viral protein -28.99 85.12 2.9 
BCL-W, Model 1 1MK3 Apoptosis regulator 25.15 72.14 2.9 
BCL-2, Isoform 1 1G5M Apoptosis regulator 46.95 133.93 2.9 
Human BID, Model 1 2BID Apoptosis regulator 100.14 259.49 2.6 
Mouse BID, Model 1 1DDB Apoptosis regulator 118.13 179.90 1.5 
Mouse BID, Model 10 1DDB Apoptosis regulator 125.99 184.24 1.5 
BCL-W, Model 10 1MK3 Apoptosis regulator 60.88 86.95 1.4 
CED-9 1OHU Apoptosis regulator -157.48 190.35 1.2 
BHRF1 1Q59 Viral protein 210.73 247.39 1.2 
 
BAX, BCL-W, BCL-XL, BCL-2 and the BCL-2 homolog of Kaposi’s sarcoma-
associated virus further separate into two subgroups. The first subgroup, represented by BAX, 
BCL-W and BCL-2 homolog of Kaposi’s sarcoma-associated virus, does not have the peripheral 
helices more stable than the core helix α5.  The second subgroup, represented by BCL-XL and 
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BCL-2, has peripheral helices more stable than the core helix α5. The helices α1 and α2 have 
energy values between -340 to -100 kcal/mol, compared to the range from -230 to 10 kcal/mol 
for the core α5 (Tables 11, 15). This difference most likely originates in their structural 
difference compared to other BCL-2 family members. Both BCL-2 and BCL-XL have a long, 
highly dynamic unstructured loop between helices α1 and α2. The dynamic nature of this region 
caused a lack of any structural information between the residues 28 and 81. Likewise, the 3D 
structure of BCL-2 was noticeably altered by the replacement of the putative flexible loop region 
with the same region from BCL-XL. This long and unstructured loop between the helices α1 and 
α2 is thought to be the main site of proteins posttranslational modifications, including 
phosphorylation and cleavage by caspases (Petros et al. 2004).  The increased stability of helices 
α1 and α2 could thus serve as an anchor for the highly flexible loop and contribute to the 
stability of the BCL-2 and BCL-XL structure. 
Human and mouse BID and BHRF1 (BCL-2 homolog from Epstein-Barr virus) displayed 
a distinctive pattern of the helical packing that differed significantly from the BAX, BCL-W, 
BCL-2 and BCL-XL. Their primary structures have low sequence homology with other BCL-2 
family members (Petros et al. 2004) and have only one conserved BH domain (BH3 in BID, BH2 
in BHRF1). Overall, the 3D structures of BID and BHRF1 displayed only 1-2 relatively stable 
helices. The pronounced hydrophobic groove and the long flexible loop between α1 and α2 
similar to those in BCL-XL and BCl-2 are absent in BID and BHRF1. Furthermore, BID lacks of 
C-terminal transmembrane domain while BHRF1 has it. The differences in the 3D structures and 
helical packing pattern indicated that different mechanisms govern the activity of BID and 
BHRF1 compared to anti-apoptotic BCL-2 or BCL-XL and pro-apoptotic BAX.  
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Table 11: Helical stability of BCL-2, BCL-W and BAX.  
Data for the helical IE values of individual helices for the representatives of BCL-2 family proteins 
demonstrating the patterns of stability observed within the various structures.  Helix numbering, amino acids in each 
helix, and the length of each helix is indicated.  This data is comparable to Figure ?, where the distribution of 
interaction energies in each structure varies for different members of the BCL-2 family.  We interpret these 
differences as an indication of potentially different mechanisms of transition for each member of the BCL-2 family.      
     
Helix 
Number 
BAX (1F16) BCL-2 (1G5M) BCL-W (1MK3) 
Sequence Helix Energy 
(kcal/mol) 
Sequence Helix Energy 
(kcal/mol) 
Sequence Helix Energy 
(kcal/mol) 
1 15-36 -58.66 10-25 -168.85 8-23 -65.22 
2 53-72 -132.36 92-109 -98.40 40-56 132.80 
3 73-81 31.02 113-118 149.96 58-70 32.24 
4 87-100 55.02 122-138 27.85 74-87 124.11 
5 107-128 -405.14 143-164 10.10 92-112 -71.19 
6 129-147 27.08 166-184 158.81 114-132 30.47 
7 149-155 104.78 184-193 68.78 133-141 -15.26 
8 158-165 89.82 194-203 227.33 142-148 6.25 
9 170-189 -76.71   154-168 52.19 
       
AVE  -40.57  46.95  25.15 
SD  158.09  133.93  72.14 
⎜SD/AVE⎜  3.90  2.85  2.87 
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 4.3.2 Homology and Topology 
 
When comparing the helical packing energies of the proteins within one family like BCL-
2 family, the question of homology as a function of energy distribution became obvious. One 
would expect a similar distribution of helical interaction energies in the case of two related 
proteins which share significant sequence homology. The BCL-2 family proteins are all involved 
in the regulation of apoptosis and have roughly similar folds, but their sequence homology is 
quite low and does not correlate with the helical interaction energy distribution. A standard 
BLAST search (NCBI BLAST, http://www.ncbi.nlm.nih.gov/BLAST) and hidden Markov 
models (HMM) (Soding et al. 2005) were used to weigh similarities in both the overall sequence 
and the individual helices themselves.  
The standard statistical parameters for the BLAST analysis include percent identity (ID), 
percent positives (P), and percent gaps (G) along the homologous number of amino acids. The 
sequence of BAX was the base for the analysis. BCL-2 and BCL-XL had the highest homology 
aligning to 152 and 147 amino acids (Table 11). The statistics for these alignments were 28% ID, 
50% (P), and 7% (G) for BCL-2 and 25% (ID), 45% (P) and 10% (G) for BCL-XL. BCL-W and 
hBID had to some extent better percentage statistics than BCL-XL, but only aligned with 132 
and 129 amino acids. This homology analysis that represents the comparison of the BAX 
sequences with the other BCL-2 family members enclosed in this study confirmed low 
homologies, and demonstrated that the variation of IE distribution within each structure has no 
correlation with the homology. 
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Table 12: BLAST sequence search of BCL-2 family members 
NCBI BLAST was used to search and obtain the statistics from the sequence alignment of the BCL-2 
family members against BAX. Standard BLAST statistics is tabulated; ID – percent identity, P – percent positives, 
G- percent gaps. 
 
 Protein No. of  amino acids 
aligned 
ID (%) P (%) G(%) 
hBCL-2 152 28 50 7 
hBCL-XL 147 25 45 10 
hBCL-W 132 28 47 12 
hBID 129 28 46 12 
mBID 65 21 42 20 
CED9 96 18 43 3 
KSHV BCL-2 78 35 47 7 
BHRF1 58 26 41 1 
 
 
 
 
 
Hidden Markov models (HMM) analysis was used to investigate the similarities of 
individual secondary structural elements in each structure. HMM analysis yields a HMM score 
and a percent identity for each sequence analyzed. BCL-XL and BCL-W had the best homology 
to BAX helices, with five helices showing HMM scores (Table 12). These helices were #2, #4, 
#5, #6 and #8m which had HMM scores as high as 36.99 at 40% identity for BCL-XL and 35.78 
(40% identity) for BCL-W. BCL-2, which had a moderate global (BLAST) alignment with BAX, 
only showed three helices (#5,#6, and #8) with HMM scores of 36.57 (33% identity), 17.74 
(21% identity) and 11.76 (25% identity). This demonstrated that the moderate homology 
between many BCL-2 family members is found in the loop regions and not within those amino 
acids that form helices. Additionally, I found no correlation between the HMM scores (and 
percent identity) and the stability of the individual helices in each structure. These homologous 
regions represent BH domain of the proteins, are similar in sequence, but vary in their respective 
stabilization of the structure. Interestingly, helices #1 and #9 from BAX have no homology 
(based on the HMM analysis) and represent two of the four helices within the BAX structure 
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with negative (favorable) IE. Given that these helices are at the termini of BAX, and the helix-9 
is known to facilitate localization of BAX to mitochondria, indicate that these helices may be 
unique in their transitional roles compared to other BCL-2 family members. 
 
 
Table 13a-c Analysis of hidden Markov Models homology of the BCL-2 family 
members. 
All listed BCL-2 family members were compared with BAX. Helix number and interaction energy (IE) is 
listed for each protein. Analysis of hidden Markov model homology (HMM) analysis is provided next to each helix 
and corresponds only to this specific helix. If no HHM score is listed, the homology (for that specific helix) is below 
the statistical homology level for the HMM server. 
a) 
 Helix Number BAX 
(1F16) 
IE (kcal/mol) BCL-2  
(1G5M) 
IE (kcal/mol) HMM score 
(% identity) 
1 15-36 -58.66 10-25 -168.85  
2 53-72 -132.36 92-109 -98.40  
3 73-81 31.02 113-118 149.96  
4 87-100 55.02 122-138 27.85  
5 107-128 -405.14 143-164 10.10 36.57 (33%) 
6 129-147 27.07 166-184 158.81 17.74 (21%) 
7 149-155 104.78 184-193 68.78  
8 158-165 89.82 194-203 227.33 11.76 (25%) 
9 170-189 -76.71    
      
AVE  -40.57  46.95  
SD  158.09  133.93  
⎜SD/AVE⎜  3.90  2.85  
 
 
 
 
 
 
b) 
Helix Number BCL-W 
(1MK3) 
IE (kcal/mol) HMM score 
(% identity) 
hBID (2BID) IE (kcal/mol) HMM score 
(% identity) 
1 8-23 -65.22  16-31 416.53  
2 40-56 132.80 19.54 (20%) 35-43 269.45  
3 58-70 32.24  81-101 58.92  
4 74-87 124.11 9.43 (29%) 107-116 84.50  
5 92-112 -71.19 35.78 (40%) 121-138 116.45  
6 114-132 30.47 19.85 (21%) 147-164 -40.76  
7 133-141 -15.26  169-182 200.88  
8 142-148 6.25 11.01 (13%) 185-194 -160.94  
9 154-168 52.19     
       
AVE  25.15   100.14  
SD  72.14   259.49  
⎜SD/AVE⎜  2.87   2.59  
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c) 
 
Helix 
Number 
mBID 
(1DDB) 
IE (kcal/mol) HMM score 
(% identity) 
CED9 
(1OHU) 
IE (kcal/mol) HMM score 
(% identity) 
1 15-27 416.53  75-78 -93.60  
2 32-39 293.92  79-95 -223.38  
3 83-100 148.88  110-139 -395.92  
4 106-113 379.87  145-154 39.50  
5 125-138 140.63  167-186 -289.80 33.32 (26%) 
6 142-162 -40.76  191-212 -383.65 16.57 (21%) 
7 167-180 200.88  213-218 36.98  
8 185-192 -160.94  220-240 50.05  
9       
       
AVE  119.13   -157.47  
SD  179.90   190.35  
⎜SD/AVE⎜  1.52   1.21  
d) 
Helix 
Number 
KSHV BCL-2 
(1K3K) 
IE (kcal/mol) HMM score 
(% identity) 
BHRF1 
(1Q59) 
IE (kcal/mol) HMM score 
(% identity) 
1 10-19 51.83  7-19 137.76  
2 34-55 -49.39  44-61 372.44  
3 61-71 31.90  61-73 193.53  
4 71-77 8.78  80-90 485.57  
5 83-101 -138.25 37.48 (41%) 98-118 -319.07  
6 105-114 32.15  121-138 360.99  
7 114-124 58.84 10.25 (14%) 139-146 134.31  
8 124-131 -165.27 13.16 (57%) 152-157 320.33  
9 134-144 -91.53     
       
AVE  -28.99   210.74  
SD  85.12   247.39  
⎜SD/AVE⎜  2.94   1.17  
 
4.3.3 Peptide Binding Changes Helical IE Distribution 
 
The pro-apoptotic proteins BCL-XL and CED9 are deposited in the PDB database in two 
forms – free and peptide bound. This gave me the opportunity to explore how the helical stability 
and packing change upon peptide binding. CED9 and BCL-XL, free and with bound peptide, are 
depicted in Figure 21. 
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Figure 21: The BH3 only peptide binds into the hydrophobic groove of BCL-XL. 
Ribbon diagrams of BCL-XL and CED9 bound to the BIM peptide and the peptide from EGL-1. Each 
peptide binds to the hydrophobic groove in both the BCL-XL and CED9 structure in a position that spans the most 
unstable (based on helical IE values) regions of both structures (represented in the Tables 14-17).  BCL-XL, CED9 
protein – teal, BIM, EGL-1 peptide – sticks. 
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The structural analysis demonstrated changes in the secondary structure upon peptide 
binding. To resolve this issue and to obtain comparable values, I performed two sets of 
calculations. The first set used the same residues for both the free and bound forms, irrespective 
of any change in the secondary structure. The second set of calculations includes the values of 
the binding energy from free and bound protein as they are designated in their PDB headers. This 
approach enabled us to compare any changes in helical interaction energy relative to the resulting 
changes in secondary structure caused by ligand (peptide) binding. Both set of calculations 
yielded similar pattern of helical stability and packing. I discuss in the detail only data sets with 
the same residues for both free and bound protein.  
Computational calculations of helical stability were performed with the peptide removed. 
The peptide was treated as a ligand and the energy of the binding was calculated. The ratio 
|SD/AVE| decreased upon ligand binding in BCL-XL (Tables 14-16) and also in CED9 (Table 
17). Free BCL-XL had a |SD/AVE| ratio of 4.38 in the complex with BIM 2.75, BAD 0.92 and 
BAK 0.95. The interaction energy between BCL-XL and BAD peptide was the strongest (-
428.93 kcal/mol; Table 16) and the lowest was between BCL-XL and BAK (-114.90 kcal/mol; 
Table 15) and BCL-XL and BIM (-132.76; Table 14).  It is important to mention that the 
peptides differ in the length by 33 amino acids in the BIM peptide, 16 amino acids in the BAK 
and 25 amino acids in BAD. Despite the differences in the peptide length, BAD and BAK 
peptides displayed different effects on the structural changes in BCL-XL compared to the BIM 
peptide. The BAD and BAK peptide seemed to significantly destabilize all the helices in the 
protein; the average energy values of the helices changed from -46.7 kcal/mol to 198.43 kcal/mol 
for BAD (Table 16).  
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Table 14: Helical stability of unbound BCL-XL and BCL-XL/BIM complex. 
Bcl-XL is shown in the table with calculations using the same atoms (not only helical regions) due to 
changes in secondary structure.  Changes in secondary structure (due to peptide binding) are shown in the second 
row. The average interaction energies (AVE), standard deviations (SD), and SD/AVE values are shown for all 
structures.  As shown, peptide binding results in a significant decrease in SD/AVE values for Bcl-XL.         
 
Helix 
Number 
BCL-XL (1MAZ) BCL-XL/BIM (1PQ1) BCL-XL/BIM (1PQ1) 
Sequence Helix Energy 
(kcal/mol) 
Sequence Helix Energy 
(kcal/mol) 
Sequence 
 
Helix Energy 
(kcal/mol) 
1 2-19 -277.61 3-19 -269.25 2-19 -227.68 
2 84-100 -342.32 82-102 -223.13 84-100 -322.04 
3 106-112 98.15 103-106 75.03 106-112 88.54 
4 120-131 104.33 107-112 113.62 120-131 63.42 
5 137-156 -238.75 118-131 39.71 137-156 -326.84 
6 160-177 23.75 136-158 -248.49 160-177 -383.01 
7 179-184 79.06 159-185 -0.82 179-184 185.12 
8 187-194 179.43 186-196 123.52 187-194 201.32 
Peptide   83-115 -132.76 83-115 -132.76 
       
AVE  -46.74  -48.73  -90.15 
SD  204.69  169.20  248.05 
⎜SD/AVE⎜  4.38  3.47  2.75 
 
BIM peptide, on the other hand, caused significant stabilization of the helices in BCL-
XL; the average energy of the helices changes from -46.74 kcal/mol to -90.15. Despite the 
different effects of the bound peptides on the structure of BCL-XL, the most dramatic energy 
changes involved helices α1, α2, α7 and α8 in all cases of BIM, BAK and BAD peptide binding. 
Furthermore, the ratio |SD/AVE| dropped below my cutoff for transitional proteins, and the 
energy values for helical stability were more evenly distributed.  
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Table 15: Helical stability of unbound BCL-XL and BCL-XL/BAK complex. 
Bcl-XL is shown in the table with calculations using the same atoms (not only helical regions) due to changes in 
secondary structure.  Changes in secondary structure (due to peptide binding) are shown in the second row. The 
average interaction energies (AVE), standard deviations (SD), and SD/AVE values are shown for all structures.  As 
shown, peptide binding results in a significant decrease in SD/AVE values for Bcl-XL.    
 
Helix 
Number 
BCL-XL (1MAZ) BCL-XL/BAK (1BXL)) BCL-XL/BAK (1BXL) 
Sequence Helix Energy 
(kcal/mol) 
Sequence Helix Energy 
(kcal/mol) 
Sequence 
 
Helix Energy 
(kcal/mol) 
1 2-19 -277.61 3-20 -148.96 2-19 -3.96 
2 84-100 -342.32 25-27 152.58 84-100 114.14 
3 106-112 98.15 42-104 301.80 106-112 261.44 
4 120-131 104.33 119-130 285.24 120-131 284.91 
5 137-156 -238.75 139-157 -24.07 137-156 6.44 
6 160-177 23.75 160-176 182.11 160-177 174.31 
7 179-184 79.06 179-185 433.45 179-184 427.25 
8 187-194 179.43 187-194 411.06 187-94 411.06 
9   199-204 206.21   
Peptide   572-587 -114.90 572-587 -114.90 
       
AVE  -46.74  199.93  209.45 
SD  204.69  190.81  166.29 
⎜SD/AVE⎜  4.38  0.95  0.79 
 
The final conclusion of the comparison among BIM, BAK and BAD binding to BCL-XL 
were: (1) the |SD/AVE| ratio significantly decreased in all cases; (2) there were significant 
changes in the interaction energy values from many of the helices; and (3) the bound peptide 
interacted with the protein at regions that have some of the highest interaction energy values 
when the protein was in the unbound form. This indicates that one can differentiate not only the 
transitional proteins from others, but also enable the prediction of the regions within the protein 
where the ligand will most likely bind. 
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Table 16: Helical stability of unbound BCL-XL and BCL-XL/BAD complex. 
Bcl-XL is shown in the table with calculations using the same atoms (not only helical regions) due to 
changes in secondary structure.  Changes in secondary structure (due to peptide binding) are shown in the second 
row. The average interaction energies (AVE), standard deviations (SD), and SD/AVE values are shown for all 
structures.  As shown, peptide binding results in a significant decrease in SD/AVE values for Bcl-XL.   
 
Helix 
Number 
BCL-XL (1MAZ) BCL-XL/BAD (1G5J) BCL-XL/BAD (1G5J) 
Sequence Helix Energy 
(kcal/mol) 
Sequence Helix Energy 
(kcal/mol) 
Sequence Helix Energy 
(kcal/mol) 
1 2-19 -277.61 2-25 -71.21 2-19 53.86 
2 84-100 -342.32 27-31 185.25 84-100 -14.41 
3 106-112 98.15 45-105 328.18 106-112 254.60 
4 120-131 104.33 106-110 -43.49 120-131 285.00 
5 137-156 -238.75 122-136 298.20 137-156 26.70 
6 160-177 23.75 139-161 460.95 160-177 186.74 
7 179-184 79.06 164-181 190.22 179-184 383.22 
8 187-194 179.43 183-212 519.87 187-194 411.75 
Peptide   301-325 -428.94 301-325 -428.94 
       
AVE  -46.74  233.50  198.43 
SD  204.69  214.03  163.07 
⎜SD/AVE⎜  4.38  0.92  0.82 
 
 
Table 17: Helical stability of unbound CED9and CED9/EGL1 complex. 
CED9 is shown in the table with calculations using the same atoms (not only helical regions) due to 
changes in secondary structure.  Changes in secondary structure (due to peptide binding) are shown in the second 
row. The average interaction energies (AVE), standard deviations (SD), and SD/AVE values are shown for all 
structures.  As shown, peptide binding results in a minor decrease in SD/AVE values for CED9.   
 
Helix 
Number 
CED9 (1OHU) CED9/EGL1 (1TY4) CED9/EGL1 (1TY4) 
Sequence Helix Energy 
(kcal/mol) 
Sequence Helix Energy 
(kcal/mol) 
Sequence 
 
Helix Energy 
(kcal/mol) 
1 75-78 -93.60 75-78 1.87 75-78 6.33 
2 79-95 -223.38 79-95 -180.92 79-95 -180.92 
3 110-139 -395.92 110-140 -241.03 110-139 -262.34 
4 145-154 39.50 141-145 30.87 145-154 -29.58 
5 167-186 -289.80 146-159 -33.44 167-186 -240.55 
6 191-212 -383.65 167-187 -155.06 191-212 -340.39 
7 213-218 36.98 191-211 -387.51 213-218 51.00 
8 220-240 50.05 220-236 -23.00 220-240 -23.00 
Peptide    -246.85  -246.85 
       
AVE  -157.48    -127.43 
SD  190.35    146.10 
⎜SD/AVE⎜  1.21    1.15 
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4.4 DISCUSSION 
    
 The BCL-2 family proteins are crucial regulators of mitochondrial apoptotic pathway. 
Their activity is thought to be regulated by significant changes in their 3D structure. The analysis 
of helical stability expressed as helical interaction energy (IE) revealed significant trends in their 
IE distribution. These transitional proteins displayed regions of high helical stability 
accompanied by regions that were relatively unstable.  
The BCL-2 family members were partitioned in subgroups according to the distribution 
of the helical stability. BAX, BCL-XL, BCL-2, BCL-W and the BCL-2 homolog from KSHV 
displayed stable core helix surrounded by rather unstable outer helices. BCL-2 and BCL-XL 
formed separate subgroups by displaying higher stability of α1 and α2 than their core helices. The 
differences in the distribution of helical stability and packing could be related to the structural 
and functional differences among BCL-2 family members. BAX, BCL-XL, BCL-2, BCL-W and 
the BCL-2 homolog from KSHV have pronounced hydrophobic pockets which modulate the 
activity of the proteins. Depending on the binding partner of the hydrophobic pocket, the 
occupancy of the pocket inhibits or facilitates the activity of the apoptotic protein. BCL-2 and 
BCL-XL also have a very long flexible loop between helices α1 and α2, which play a significant 
role in the regulation of the activity of BCL-XL and BCL-2 (Borner 2003;Petros et al. 2004). 
The BH3-only protein BID and the BCL-2 homolog from EBV did not group with the other 
members of BCL-2 family, indicating that varied helical stability mediates structural transitions 
specific to the function of the protein. 
The occupancy of the hydrophobic pocket is predicted to regulate the intracellular 
distribution of these proteins and consequently their activity (Denisov et al. 2003;Petros et al. 
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2004;Petros et al. 2000;Tschammer et al. 2007b). Latent BAX is a cytosolic protein in healthy 
cells, with the α9 helix sequestered within a hydrophobic pocket (Suzuki et al. 2000).  During 
apoptosis, BAX may undergo a conformational change that exposes transmembrane domains, 
helix α9 and possibly helix α5 and α6, to promote mitochondrial membrane binding (Annis et 
al. 2005).  Similarly, BCL-W has its C-terminal helix folded into its hydrophobic pocket when 
localized in the cytosol. In response to apoptotic stimuli, helix α9 is exposed and inserts into the 
mitochondrial membranes (Denisov et al. 2003). The activity of the BCL-2 family proteins thus 
seems to be regulated by the occupancy of the hydrophobic pocket. It is possible that the also the 
helical stability of these proteins is regulated by the occupancy of the hydrophobic pocket.  I 
predict that the more stable structures, with hydrophobic pockets occupied by their C-terminal 
helices, such as BAX or BCL-W, will not undergo structural transitions unless their C-terminal 
helix is released or displaced from the pocket. This C-terminal α9 helix is one of the helices that 
stabilize the 3D structure of the protein. These data support the role of the α9 helix as a type of 
transitional switch that allows translocation of BAX from the cytosol to the mitochondria upon 
apoptotic stimuli(Tschammer et al. 2007b).   
BCL-XL, whose structure was determined with both an unoccupied pocket (displaying 
the most flexible helices) and with peptides bound, demonstrated that the structural stabilization 
occur upon binding of the BH3 peptides (BIM, BAD and BAK), but the extent of structural 
changes depends on the binding partner. These data corroborate binding studies that were done 
with BH3 peptides measured by plasmon resonance (Kuwana et al. 2005).  In this study, the BIM 
peptide had a dissociation constant of 9.2 ± 5.3 nM, and the BAD peptide had a binding constant 
of 2.05 ± 0.8 nM.  These data correlate well to my calculated binding energies for the peptides 
 105
and demonstrates that the increase in (shown through my calculations and the dissociation 
constants) affinity may regulate how much of a structural transition BCL-XL undergoes during 
binding to different partners.  
This may be a direct link to the functional role that each BCL-2 family member has in the 
presence of various BH3 containing proteins. My findings indicate that the function of the BCL-
2 family members may be dependent on which BH-3 containing proteins interact with. The 
current dogma states that the BH3-only proteins can be functionally subdivided into activators, 
like BID and BIM, which induce the oligomerization of BAX and BAK, and sensitizers, like 
BAD, NOXA or PUMA, which directly bind anti-apoptotic proteins (Certo et al. 2006). I 
propose hat these activators or sensitizers both bind anti-apoptotic proteins, but may have 
different consequences upon the stability of the anti-apoptotic proteins and its ability to transition 
during apoptosis. The binding of BH3-peptides (or the entire BH3-only proteins) like that of 
BAD to the hydrophobic groove may “lock” BCL-2 family protein into a structural state that is 
resistant to conformational transitions, thereby negating its pro- or anti- apoptotic function, while 
binding BIM may favor a degree of transitioning. By understanding how the interaction energy 
(in the reference to the in vitro binding data) correlates with the level of structural transition, a 
potential link between the various functions of BCL-2 family member with the respect to their 
BH3 protein binding partners can be established.  
The analysis of the helical stability contributes certain degree of knowledge to the 
understanding how BCL-2 regulators of apoptosis undergo transitions, but additional studies are 
required that better represent the biological conditions in vivo. Many of BCL-2 family proteins 
are involved in membrane binding that allows the insertion into various organelles, most 
noticeably mitochondria. These types of structural transitions cannot be accurately represented 
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by the analysis where the proteins are considered static structures. The nature of these 
transitional mechanisms, which are not amendable to current methods for high resolution 
structure determination (because of the membrane binding and sample heterogeneity), represents 
the dynamic nature of polypeptides and give insight into their mechanism of action. In the 
absence of such high resolution data, our analysis of the static stability of the individual helices 
gives insight into the protein’s mechanism of action, as well as enabling classification and 
identifying peptide binding location. 
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5 CONCLUSIONS 
 
Apoptosis is essential for the development and the maintenance of cellular homeostasis.  
Proteins of the BCL-2 family are key modulators of this process.  In response to diverse 
apoptotic stimuli, the pro-apoptotic member of BCL-2 family BAX redistributes from the cytosol 
to the mitochondria or endoplasmic reticulum and primes cells for death.  The activation of this 
lethal protein is poorly understood.  
My study is comprised of three parts. First part was governed by the hypothesis that the 
C-terminal α9 helix of BAX crucially regulates the intracellular distribution and activation of 
BAX, not as putative membrane domain, but as “molecular switch” that triggers conformational 
changes of BAX needed for the redistribution from the cytosol to mitochondrial membrane. 
Computational analysis using molecular mechanics and computational docking using web based 
server GRAMM-X indicated that the C-terminal α9 helix of BAX can dock into the hydrophobic 
pocket of BAX in two directions – in forward orientation that occurs during self-association and 
reverse orientation that might occur during dimerization. Co-immunoprecipitation and 
crosslinking demonstrated that an EGFP tagged α9 helix of BAX associated with BAX lacking 
its C-terminal. Peptide encoding last 20 amino acids of BAX efficiently induced the translocation 
of wild type and C-terminally truncated BAX into the mitochondria, further confirming that the 
C-terminal α9 helix of BAX serves as a “molecular switch”, triggering conformational changes 
in BAX which are needed for the redistribution from cytosol to mitochondria. This is novel 
discovery, which is not important only to reach a fuller understanding of how BAX is regulated, 
but will enable the design of novel therapeutics which could modulate the activity of BAX. 
Studies using peptides encoding BH3 domain sequences or small-molecule BCL-2 antagonists, 
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which bound to the hydrophobic groove of BCL-2 with high affinity, showed that these 
substances can act as competitive inhibitors of BCL-2 function, inducing the selective death of 
cancer cells.  We propose that similar peptides or small molecules derived from the sequence of 
C-terminal α9 of BAX could in the same fashion inhibit or activate the function of BAX. As 
example a small molecule could cause a displacement of self-associated C-terminus of BAX, 
triggering conformational changes in BAX that lead to association with mitochondrial outer 
membrane and induction of apoptosis. Specific targeting of such a compound to tumors or cancer 
cells could trigger the apoptosis of these pathogenic cells. On the other hand, the design of a 
peptide that would “lock” the C-terminal α9 of BAX and prevent its release could protect cells 
from apoptosis in e.g. neurodegenerative, myocardic and ischemic diseases.  
The second part of the study was computational and focused on examining the helical 
stability of proteins. As a result my study, it became evident that BAX has a broad variation in 
the distribution of the helical interaction energy, ranging from stable core helix to destabilized 
helices on the periphery. This led to hypothesis that proteins which undergo 3D structural 
transitions during execution of their function have broad variation in the distribution of the 
helical interaction energy compared to the proteins which do not undergo such transitions. 
Computational analysis of a random set of all-alpha proteins from the Protein Data Bank 
demonstrated that the analysis of the helical interaction energy within the proteins yields a 
measure of the propensity of the protein to undergo transitions and can be used to predict the 
likelihood that the protein analyzed will undergo transitions.  No measure of the propensity for 
such transitions is currently available for stable proteins that are involved in signaling. Hence, I 
developed a novel computational method for the prediction of the propensity for transition. With 
an increasing number of protein structures being determined by structural genomics, parameters, 
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such as the propensity for transition, will provide needed information about the areas of least 
stability within a protein’s 3D structure and possibly identify novel region(s) of contacts for the 
biological molecules that are involved in the interaction(s). This information may aid in the 
design of experiments to elucidate a protein’s function in the context of its interaction with the 
surfaces with other protein or ligands.  
The third part of the study was a computational analysis of the BCL-2 family, using the 
computational method developed in the second part of the study.  I used this method to estimate 
the propensity of individual BCL-2 family members to undergo transitions in relation to changes 
in the distribution of the helical interaction energy upon ligand binding. The analysis resulted in 
a strong correlation between the computational results and published experimental findings, 
confirming the ability of the computational method to predict transitional proteins. Most 
importantly, the computational method revealed that the binding of the ligand, such as a peptide, 
to a protein can have stabilizing or destabilizing effect, carrying important consequences for the 
activation or repression of the protein.  One example of this is the previously described dual 
function of the C-terminal α9 of BAX that is dependent upon the orientation of its binding to the 
hydrophobic groove.  A similar trend was observed for the anti-apoptotic protein, BCL-XL, in 
that binding of a BH3 peptide from BIM, stabilized the protein, while binding of a BH3 peptide 
from BAD within the same groove destabilized the protein.  Furthermore, the distribution of IE 
values decreased in the specific regions of the proteins which displayed the least structural 
stability, indicating a potential application for the identification of the binding site for the ligand. 
This computational analysis thus contributes to the better understanding of the function and 
regulation of the BCL-2 family members.  
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